Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.0851536436980794e-35,17.165027137042063,1381.9349930225883,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPL23', 'RPS5', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",5.621095874356051e-33,0,0,65
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.7292709209761535e-17,6.7597826086956525,257.8175143031192,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'ATP5MC3', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1B', 'UCP3', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'NDUFA7', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'SLC25A5', 'SLC25A4', 'SLC25A6']",7.0688116853282374e-15,0,0,47
3,Oxidative phosphorylation WP623,1.872054729156885e-09,5.932716445258818,119.2252296028845,"['NDUFB9', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB5', 'NDUFB2', 'ATP5MC3', 'ATP5MC1', 'ATP5F1B', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA7', 'NDUFA6', 'ATP6AP1', 'NDUFA4', 'NDUFA3', 'ATP6AP2', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'ATP5PO']",3.2324144990108883e-07,0,0,26
4,Nonalcoholic fatty liver disease WP4396,5.214342743816617e-09,3.1759214388761703,60.57070614946106,"['NDUFB9', 'NDUFA13', 'COX7B', 'GSK3A', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'CASP7', 'CASP8', 'LEPR', 'UQCRFS1', 'CYC1', 'COX8A', 'XBP1', 'JUN', 'NDUFA7', 'TGFB1', 'NDUFA6', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",6.752573853242519e-07,0,0,46
5,Mitochondrial CIV Assembly WP4922,3.516696021750346e-06,5.682626538987688,71.36235951815111,"['COX8A', 'COA3', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX7C', 'COX6B1', 'SCO2', 'COX14']",0.00036432970785333583,0,0,16
6,Mitochondrial complex I assembly model OXPHOS system WP4324,1.5873650034677725e-05,3.791076595096696,41.894618995593326,"['NDUFB9', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFA3', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'TMEM70', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAF3']",0.0013704251196605102,0,0,20
7,Selenium Micronutrient Network WP15,0.00011115431923997693,3.2718278677182786,29.788654750197356,"['SERPINA3', 'GPX2', 'GPX4', 'DIO1', 'KMO', 'SELENOK', 'SELENOH', 'SOD1', 'PRDX3', 'PRDX2', 'SELENOM', 'PRDX5', 'RFK', 'PRDX1', 'SELENOW', 'PNPO', 'SEPHS2', 'LDLR', 'MSRB1']",0.008225419623758293,0,0,19
8,Allograft Rejection WP2328,0.00021575355975840776,3.7022908327057986,31.25242057112537,"['C1QB', 'C1QA', 'ABCB1', 'TGFB1', 'HLA-B', 'HLA-A', 'HLA-E', 'C2', 'TUBA1B', 'CASP7', 'CASP8', 'C6', 'IL5', 'CXCL12', 'VIM']",0.013970042994356903,0,0,15
9,Computational Model of Aerobic Glycolysis WP4629,0.00032534332202113027,9.913487738419619,79.61154765261234,"['LDHA', 'TPI1', 'PKM', 'PGK1', 'ENO1', 'ALDOA', 'GAPDH']",0.018725315645216165,0,0,7
10,Glycolysis and Gluconeogenesis WP534,0.0005528318366197391,4.0036413290851165,30.029138413515057,"['LDHA', 'TPI1', 'PKM', 'GOT1', 'MDH2', 'PGAM1', 'PGK1', 'ALDOC', 'ENO1', 'ENO2', 'ALDOA', 'GAPDH']",0.026605341537997134,0,0,12
11,Proximal tubule transport WP4917,0.0005803814349343487,3.4538971971872834,25.737837564806973,"['ATP6V1G1', 'SLC13A3', 'ATP6V0B', 'SLC22A6', 'ABCC2', 'ABCB1', 'SLC3A1', 'ATP1B1', 'SLC7A7', 'SLC7A9', 'ATP6V0A4', 'ATP6V1E1', 'ATP6V0C', 'ATP6V1F']",0.026605341537997134,0,0,14
12,Mitochondrial complex III assembly WP4921,0.0006163399584092,6.475498150191472,47.86501651584982,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.026605341537997134,0,0,8
13,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.0013918673624979947,2.508920038228735,16.50144058170766,"['PSMD10', 'HSPA8', 'HSPA1L', 'HSPA5', 'TUBB', 'UBE2L6', 'TUBA4A', 'PSMD8', 'TUBB8', 'TUBA1B', 'TUBB6', 'TUBB2B', 'CASP8', 'TUBA1A', 'TUBB2A', 'TUBB3', 'STUB1', 'HSPA1B', 'HSPA1A']",0.05546056105953548,0,0,19
14,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.0026836306449285804,6.794189741261915,40.225575715547066,"['CDKN1A', 'GALNT3', 'CCND1', 'SPP1', 'ROS1', 'PHEX']",0.09267471160486697,0,0,6
15,Glycolysis in senescence WP5049,0.0026836306449285804,6.794189741261915,40.225575715547066,"['LDHA', 'PKM', 'PGK1', 'ALDOC', 'ENO1', 'GAPDH']",0.09267471160486697,0,0,6
16,Complement system WP2806,0.003086051379294348,2.737978163537821,15.82787632096046,"['PRNP', 'FKBP2', 'F10', 'C5AR1', 'WAS', 'F13A1', 'C4BPA', 'C2', 'C6', 'RPS19', 'SPP1', 'MASP2', 'CD59', 'CALR']",0.09779960742723462,0,0,14
17,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.003398441956930933,inf,inf,"['TGFB1', 'IL5', 'VIP']",0.09779960742723462,0,0,3
18,Gastric acid production WP2596,0.003398441956930933,inf,inf,"['CCK', 'VIP', 'MUC6']",0.09779960742723462,0,0,3
19,Cholesterol Biosynthesis Pathway WP197,0.003643765430834531,4.955154405086285,27.821892113755187,"['IDI1', 'SQLE', 'HMGCS1', 'MSMO1', 'HMGCR', 'DHCR7', 'FDFT1']",0.09934055227222563,0,0,7
20,Complement and Coagulation Cascades WP558,0.0042007089522401566,3.3333333333333335,18.24167323261734,"['C1QB', 'C1QA', 'CPB2', 'C6', 'SERPIND1', 'F10', 'C5AR1', 'MASP2', 'F5', 'C2']",0.10879836186302005,0,0,10
21,Galanin receptor pathway WP4970,0.004687927332669736,5.661370857921017,30.36059994637005,"['CDKN1C', 'YAP1', 'CDKN1A', 'CDKN1B', 'PRKCD', 'VAMP2']",0.11563554087252016,0,0,6
22,TYROBP causal network in microglia WP3945,0.005667304347591289,3.147895508059219,16.284194724129048,"['APBB1IP', 'CD4', 'SLC7A7', 'IGSF6', 'ADAP2', 'IL18', 'SPP1', 'LHFPL2', 'SAMSN1', 'TMEM106A']",0.13153750546358467,0,0,10
23,Drug Induction of Bile Acid Pathway WP2289,0.00593328250497327,11.31609977324263,58.01965414769461,"['ABCB1', 'ABCC2', 'SLC10A1', 'SLC51A']",0.13153750546358467,0,0,4
24,Exercise-induced Circadian Regulation WP410,0.006094401797540602,2.4806947608200454,12.65249752231423,"['IDI1', 'DAZAP2', 'HSPA8', 'CEBPB', 'RBPMS', 'GSTP1', 'G0S2', 'PER2', 'DNAJA1', 'CLDN5', 'TUBB3', 'UCP3', 'SUMO3', 'EIF4G2']",0.13153750546358467,0,0,14
25,Oxidative Damage WP3941,0.006854918317002054,2.8334849863512286,14.118657486926317,"['C1QB', 'CDKN1C', 'C1QA', 'CDKN1A', 'PCNA', 'CDKN1B', 'GADD45A', 'C5AR1', 'CYCS', 'NFKBIE', 'C2']",0.14203390752828254,0,0,11
26,Cori Cycle WP1946,0.007608070283178222,4.852214512677517,23.671750322574333,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA', 'GAPDH']",0.15157616948793534,0,0,6
27,Complement Activation WP545,0.009963403892596482,5.659255898366606,26.082585200917247,"['C1QB', 'C1QA', 'C6', 'MASP2', 'C2']",0.19114974875425844,0,0,5
28,Spinal Cord Injury WP2431,0.011565677898294456,1.9231751980240184,8.57681014088139,"['C1QB', 'TGFB1', 'CDKN1B', 'IL1R1', 'GADD45A', 'MIF', 'PDYN', 'NTN1', 'GFAP', 'TNFSF13B', 'RHOB', 'NR4A1', 'ZFP36', 'CCND1', 'APEX1', 'SLIT3', 'LTB', 'SLIT2', 'VIM', 'ROS1']",0.20099971149680118,0,0,20
29,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.011640909932247173,4.245347253744893,18.905506336502427,"['CD63', 'EGF', 'CD81', 'SPP1', 'HSPB1', 'SOD1']",0.20099971149680118,0,0,6
30,Hypertrophy Model WP516,0.011640909932247173,4.245347253744893,18.905506336502427,"['JUND', 'NR4A3', 'MSTN', 'WDR1', 'IL1R1', 'IL18']",0.20099971149680118,0,0,6
31,Senescence and Autophagy in Cancer WP615,0.015230641300777595,1.8598207131035205,7.782319353386892,"['GABARAPL2', 'GABARAPL1', 'JUN', 'CDKN1A', 'CEBPB', 'TGFB1', 'CDKN1B', 'PCNA', 'IGFBP5', 'IGFBP3', 'FN1', 'HMGA1', 'CXCL14', 'GABARAP', 'BMP2', 'MAP1LC3B', 'MAP1LC3A', 'IRF1', 'HRAS', 'SLC39A3']",0.2544991030258966,0,0,20
32,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.021519836646226073,5.6571428571428575,21.716527618063164,"['CCND1', 'EGF', 'FN1', 'VIM']",0.34835235571078454,0,0,4
33,Thyroxine (Thyroid Hormone) Production WP1981,0.02261284431749837,inf,inf,"['TG', 'TSHR']",0.35495313201406536,0,0,2
34,Dopaminergic Neurogenesis WP2855,0.024131318703547025,4.041677469535909,15.052196100660764,"['CDKN1C', 'TGFB1', 'ASCL1', 'SLC18A2', 'GLI2']",0.36764773789521643,0,0,5
35,IL-18 signaling pathway WP4754,0.02603626396063521,1.4682659798143116,5.356623304135068,"['CEBPB', 'EPB41', 'CD81', 'RGS16', 'COX17', 'HSPB1', 'ENO1', 'PLD1', 'RND2', 'ACACB', 'CASP8', 'TMSB4X', 'FAM186B', 'SPP1', 'FADD', 'JUN', 'TICAM2', 'USP5', 'IMP3', 'PRKCD', 'FN1', 'IL18', 'NDUFC1', 'BPGM', 'EEF2', 'CCNA2', 'NR4A1', 'ARL4D', 'BMP2', 'IRF1', 'RFX5', 'CYCS', 'BAX', 'LTB', 'NFKBIE', 'ITM2C', 'ARF6', 'MYH7']",0.38533670661740116,0,0,38
36,Type II interferon signaling (IFNG) WP619,0.02903063051250376,2.8301544050862852,10.017059204551469,"['CIITA', 'SPI1', 'IRF1', 'PRKCD', 'IFI6', 'HLA-B', 'ISG15']",0.4177185168188041,0,0,7
37,Vitamin D Receptor Pathway WP2877,0.031828480512593446,1.6924514021941457,5.834546430808936,"['COLEC11', 'CDKN1A', 'ABCB1', 'TGFB1', 'CDKN1B', 'CDKN2C', 'IGFBP5', 'GADD45A', 'IGFBP3', 'G0S2', 'CYP3A5', 'CEACAM1', 'DUSP10', 'CCND1', 'BGLAP', 'PNOC', 'TIMP2', 'SPP1', 'LGALS9', 'ZNF257']",0.4385276896061023,0,0,20
38,Nanomaterial induced apoptosis WP2507,0.032169984951799006,3.0867824866917015,10.608411446143785,"['CASP7', 'ENDOG', 'CASP8', 'BAX', 'CYCS', 'FADD']",0.4385276896061023,0,0,6
39,Cytokines and Inflammatory Response WP530,0.03419145739979639,4.525351473922902,15.276588508548466,"['CD4', 'TGFB1', 'IL5', 'IL7']",0.4541326905921675,0,0,4
40,Cellular Proteostasis WP4918,0.04763947870195641,5.655031731640979,17.214445206511492,"['VBP1', 'PFDN5', 'PFDN6']",0.565069769416259,0,0,3
41,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.04763947870195641,5.655031731640979,17.214445206511492,"['HEY1', 'VEGFB', 'VEGFC']",0.565069769416259,0,0,3
42,Glucocorticoid Receptor Pathway WP2880,0.048345967463649754,1.8877256865422547,5.718624213618768,"['CDKN1C', 'RGS2', 'HSP90AA1', 'MGAM', 'JUN', 'GADD45B', 'TSC22D3', 'B3GNT5', 'SPINK13', 'SPRY1', 'ANGPTL4', 'MFGE8']",0.565069769416259,0,0,12
43,Pathogenic Escherichia coli infection WP2272,0.048345967463649754,1.8877256865422547,5.718624213618768,"['TUBB8', 'TUBA1B', 'TUBB6', 'TUBB2B', 'TUBA1A', 'TUBB2A', 'TUBB3', 'TUBB', 'WAS', 'ACTB', 'TUBA4A', 'ACTG1']",0.565069769416259,0,0,12
44,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.049089072632686595,2.264061790095411,6.824151256277409,"['NDUFA13', 'CASP7', 'HSP90AA1', 'CASP8', 'ACAP1', 'IL18', 'NLRC4', 'AAMP']",0.565069769416259,0,0,8
45,Peptide GPCRs WP24,0.049089072632686595,2.264061790095411,6.824151256277409,"['MC4R', 'C5AR1', 'GNRHR', 'TAC4', 'SSTR1', 'NMBR', 'TSHR', 'HCRTR2']",0.565069769416259,0,0,8
46,Ovarian infertility WP34,0.05418588777219061,2.611473864310905,7.613320577540061,"['CEBPB', 'CDKN1B', 'MSH5', 'ZP3', 'INHA', 'PRLR']",0.6101802144781464,0,0,6
47,"GPCRs, Class A Rhodopsin-like WP455",0.0567377230580807,1.5833333333333333,4.543083634687238,"['NPFFR2', 'P2RY12', 'GPR39', 'P2RY14', 'CHRM5', 'HTR2B', 'NMBR', 'GPR3', 'SSTR1', 'ADRA2C', 'MCHR1', 'HCRTR2', 'MC4R', 'ADORA2A', 'LPAR6', 'GPER1', 'ACKR4', 'RGL4', 'OR3A2']",0.6253221392358681,0,0,19
48,Pyrimidine metabolism WP4022,0.06311440265274917,1.605124695863747,4.434648596734278,"['POLR2J3', 'ENTPD1', 'NME2', 'DCK', 'NME1', 'TYMP', 'NT5C', 'POLD1', 'POLE2', 'POLR1C', 'POLE3', 'POLR2E', 'POLR2I', 'DCTPP1', 'POLR3K', 'POLR2K', 'POLR2L']",0.6811095952942514,0,0,17
49,Urea cycle and associated pathways WP4595,0.06791196254707142,2.4247454769470203,6.521457420802691,"['SLC25A15', 'OAT', 'GOT1', 'MDH2', 'PYCR1', 'ASL']",0.6889679857142106,0,0,6
50,7q11.23 copy number variation syndrome WP4932,0.06879785637482401,1.5378473581213308,4.116175621486964,"['CDKN1C', 'PCNA', 'H2AFX', 'HMGA1', 'ATP5MC3', 'UBE2L6', 'ACACB', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'CLDN5', 'ATP5F1B', 'CFL1', 'BCL7B', 'EIF4H', 'ATP5PO', 'GTF2IRD1', 'GAPDH', 'VAMP2']",0.6889679857142106,0,0,19
51,Development and heterogeneity of the ILC family WP3893,0.06995131818767157,3.2318756073858115,8.59664605129222,"['IL5', 'IL7', 'ID2', 'IL18']",0.6889679857142106,0,0,4
52,Aryl Hydrocarbon Receptor Pathway WP2873,0.07019555960332981,2.2005247754566555,5.845628541997126,"['HSP90AA1', 'JUN', 'CDKN1B', 'TGFB1', 'JUND', 'AIP', 'BAX']",0.6889679857142106,0,0,7
53,Lung fibrosis WP3624,0.07049286340319144,2.0579075626781216,5.458072579460122,"['EDN1', 'CEBPB', 'TGFB1', 'IL5', 'EGF', 'SFTPC', 'SPP1', 'FGF1']",0.6889679857142106,0,0,8
54,Dual hijack model of Vif in HIV infection WP3300,0.0742190244175638,4.240933816863101,11.029544025897213,"['UBB', 'ELOB', 'RUNX1']",0.6990082663326918,0,0,3
55,Mevalonate pathway WP3963,0.0742190244175638,4.240933816863101,11.029544025897213,"['HMGCS1', 'HMGCR', 'ACAT2']",0.6990082663326918,0,0,3
56,Pregnane X receptor pathway WP2876,0.07969197594963967,2.5711516251443656,6.503950122693345,"['HSP90AA1', 'ABCB1', 'ABCC2', 'CYP3A5', 'CYP3A7']",0.7242183077528659,0,0,5
57,Urea cycle and metabolism of amino groups WP497,0.07969197594963967,2.5711516251443656,6.503950122693345,"['OAT', 'ODC1', 'PYCR1', 'ASL', 'CKB']",0.7242183077528659,0,0,5
58,Nuclear Receptors Meta-Pathway WP2882,0.08214475210482146,1.3090038993264799,3.271557210269585,"['CDKN1C', 'ABCB1', 'CDKN1B', 'HSP90AB1', 'SRXN1', 'GSTP1', 'SLC5A3', 'CYP3A5', 'CYP3A7', 'DNAJB1', 'RGS2', 'CCND1', 'PRDX1', 'SLCO2B1', 'SLC39A7', 'CBR3', 'SLC39A3', 'JUN', 'HSP90AA1', 'GPX2', 'JUND', 'TGFB1', 'ABCC2', 'GADD45B', 'SLC10A1', 'TSC22D3', 'SLC2A12', 'SLC39A11', 'AIP', 'SLC2A9', 'B3GNT5', 'MAFF', 'SPINK13', 'BAX', 'SPRY1', 'ANGPTL4', 'MFGE8', 'HSPA1A', 'FKBP5']",0.7336376136258193,0,0,39
59,ID signaling pathway WP53,0.09286133569652406,2.8276643990929706,6.7203626913896235,"['PAX8', 'ID2', 'ID3', 'ELK3']",0.8152910489966011,0,0,4
60,Apoptosis Modulation by HSP70 WP384,0.09949281778112057,2.3566999395039323,5.438485326431577,"['CASP7', 'CASP8', 'CYCS', 'FADD', 'HSPA1A']",0.8306723564184703,0,0,5
61,Imatinib and Chronic Myeloid Leukemia WP3640,0.09949281778112057,2.3566999395039323,5.438485326431577,"['SPRED2', 'ABCB1', 'CDKN1B', 'GADD45A', 'PIM1']",0.8306723564184703,0,0,5
62,Bile acids synthesis and enterohepatic circulation  WP4389,0.10583856278690934,3.3924750679963736,7.618957354649491,"['SLC10A1', 'FGFR4', 'LDLR']",0.8306723564184703,0,0,3
63,Biomarkers for urea cycle disorders WP4583,0.10583856278690934,3.3924750679963736,7.618957354649491,"['F10', 'GOT1', 'ASL']",0.8306723564184703,0,0,3
64,HIF1A and PPARG regulation of glycolysis WP2456,0.10583856278690934,3.3924750679963736,7.618957354649491,"['LDHA', 'TPI1', 'GAPDH']",0.8306723564184703,0,0,3
65,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.10583856278690934,3.3924750679963736,7.618957354649491,"['MMP25', 'CD4', 'CD247']",0.8306723564184703,0,0,3
66,Selective expression of chemokine receptors during T-cell polarization WP4494,0.10583856278690934,3.3924750679963736,7.618957354649491,"['CD4', 'TGFB1', 'IL5']",0.8306723564184703,0,0,3
67,Codeine and Morphine Metabolism WP1604,0.11002134770404247,5.65292251925691,12.476457106519705,"['ABCB1', 'ABCC2']",0.8381037957455,0,0,2
68,Nucleotide GPCRs WP80,0.11002134770404247,5.65292251925691,12.476457106519705,"['ADORA2A', 'LPAR6']",0.8381037957455,0,0,2
69,Cytosolic DNA-sensing pathway WP4655,0.11480228095715582,1.664392905866303,3.6026515554184546,"['CASP8', 'TRADD', 'POLR1C', 'IL18', 'POLR2E', 'ISG15', 'FADD', 'POLR3K', 'POLR2K', 'POLR2L']",0.8618490077653147,0,0,10
70,miRNAs involved in DNA damage response WP1545,0.11881822620140244,2.513277903754094,5.353685227173443,"['CDKN1A', 'CDKN1B', 'CCND1', 'H2AFX']",0.879254873890378,0,0,4
71,Metabolic reprogramming in colon cancer WP4290,0.12128437337550428,1.6974545454545455,3.580979470953501,"['LDHA', 'PKM', 'MDH2', 'PGAM1', 'PGK1', 'PYCR1', 'ENO1', 'SLC16A3', 'GAPDH']",0.8848634564579044,0,0,9
72,VEGFA-VEGFR2 Signaling Pathway WP3888,0.13318597024552914,1.1783012851080064,2.3754658245299285,"['TRAF3IP2', 'HSPB1', 'RPL10A', 'ETS1', 'RPL7', 'ACTG1', 'TUBB8', 'RPS6KA5', 'RPL18A', 'CCND1', 'TMSB4X', 'CFL1', 'RPLP2', 'SH3BGRL3', 'CHAC1', 'ATP6V1E1', 'IER5', 'HRAS', 'DUSP5', 'HSP90AA1', 'SSR4', 'TRPC3', 'IGFBP3', 'PRKCD', 'GAB1', 'RPL13A', 'DKK1', 'TXNIP', 'RPL27', 'RPL26', 'ALDOA', 'GAPDH', 'SLC25A11', 'FJX1', 'ARF6', 'KANK1', 'SET', 'TNXB', 'EPB41', 'FOXO4', 'ACACB', 'APOLD1', 'PRDX2', 'STIP1', 'LDHA', 'DNAJB4', 'PGK1', 'DNAJB9', 'MYH11', 'FADD', 'CCT7', 'JUN', 'SDF2L1', 'FN1', 'BMX', 'DNAJA1', 'NR4A1', 'BMP2', 'NR4A3', 'CYCS', 'HYOU1', 'PTPN6', 'CALR', 'EIF4G2', 'HSPA1A']",0.9120732848784953,0,0,65
73,Translation Factors WP107,0.13472383433842727,1.556164695177434,3.1193761201429426,"['EIF4A2', 'EEF1B2', 'EIF5A', 'EEF1G', 'EEF1A1', 'EIF1AX', 'EIF3I', 'EEF1A2', 'EIF4H', 'EEF2', 'EIF1']",0.9120732848784953,0,0,11
74,Acute viral myocarditis WP4298,0.1394701289671324,1.509088150508269,2.972760036457551,"['CASP7', 'EDN1', 'CD4', 'CASP8', 'ENDOG', 'TGFB1', 'CCND1', 'CYCS', 'BAX', 'ACTB', 'SGCG', 'EIF4G2']",0.9120732848784953,0,0,12
75,Blood Clotting Cascade WP272,0.14166213422721124,2.826835902085222,5.5245147825469,"['F8A1', 'F10', 'F5']",0.9120732848784953,0,0,3
76,Farnesoid X receptor pathway WP2879,0.14166213422721124,2.826835902085222,5.5245147825469,"['SLC10A1', 'SLCO2B1', 'FKBP5']",0.9120732848784953,0,0,3
77,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.14166213422721124,2.826835902085222,5.5245147825469,"['ANXA2', 'LDLRAP1', 'LDLR']",0.9120732848784953,0,0,3
78,Osteoclast Signaling WP12,0.14166213422721124,2.826835902085222,5.5245147825469,"['AIMP2', 'ATP6V1G1', 'SPP1']",0.9120732848784953,0,0,3
79,Trans-sulfuration pathway WP2333,0.14166213422721124,2.826835902085222,5.5245147825469,"['AHCY', 'GOT1', 'MAT2B']",0.9120732848784953,0,0,3
80,Cell cycle WP179,0.14370768497267217,1.3616611756545864,2.6415872885354963,"['CDKN1C', 'ANAPC13', 'CDKN1A', 'TGFB1', 'CDKN1B', 'PCNA', 'CDKN2C', 'GADD45B', 'GADD45A', 'YWHAB', 'CDC14A', 'ANAPC11', 'SMC1B', 'CCNA2', 'CCND1', 'PTTG1', 'YWHAG', 'SKP1', 'YWHAH']",0.9120732848784953,0,0,19
81,Fas ligand pathway and stress induction of heat shock proteins WP314,0.14517661338704047,1.6761404748683257,3.23462301935838,"['CASP7', 'JUN', 'CASP8', 'HSPB1', 'CYCS', 'FADD', 'ACTB', 'ACTG1']",0.9120732848784953,0,0,8
82,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.1455353941380555,2.019704433497537,3.8926489898604952,"['H3F3B', 'H2AFZ', 'H3F3A', 'H2AFX', 'PCGF1']",0.9120732848784953,0,0,5
83,ERK Pathway in Huntington's Disease WP3853,0.14749163007923746,2.261768707482993,4.328988778643414,"['CASP7', 'RPS6KA5', 'EGF', 'HRAS']",0.9120732848784953,0,0,4
84,Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs) WP688,0.15040486280181098,inf,inf,['FMO5'],0.9120732848784953,0,0,1
85,"COVID-19, thrombosis and anticoagulation WP4927",0.15040486280181098,inf,inf,['F13A1'],0.9120732848784953,0,0,1
86,Base Excision Repair WP4752,0.153932713560105,1.7214587529123722,3.2212619551674524,"['FEN1', 'PCNA', 'NEIL2', 'POLD1', 'APEX1', 'POLE2', 'POLE3']",0.9120732848784953,0,0,7
87,Hematopoietic Stem Cell Differentiation WP2849,0.16283348911053785,1.7859378359653104,3.2415256417392753,"['CIITA', 'SPI1', 'TNXB', 'IL5', 'PIM1', 'RUNX1']",0.9120732848784953,0,0,6
88,Ferroptosis WP4313,0.16352766596034368,1.6161485039267864,2.926478223898158,"['PRNP', 'MAP1LC3B', 'MAP1LC3A', 'GPX4', 'PCBP1', 'ACSL5', 'VDAC2', 'CP']",0.9120732848784953,0,0,8
89,Glycogen Synthesis and Degradation WP500,0.16352766596034368,1.6161485039267864,2.926478223898158,"['GYS2', 'GSK3A', 'PHKG1', 'PPP2R1A', 'CALM3', 'GYG2', 'CALM1', 'CALM2']",0.9120732848784953,0,0,8
90,ACE Inhibitor Pathway WP554,0.1655113682984142,3.768312943664099,6.77812250833505,"['TGFB1', 'ATP6AP2']",0.9120732848784953,0,0,2
91,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.1655113682984142,3.768312943664099,6.77812250833505,"['COX8A', 'GSTP1']",0.9120732848784953,0,0,2
92,EV release from cardiac cells and their functional effects WP3297,0.1655113682984142,3.768312943664099,6.77812250833505,"['CXCL12', 'RGS16']",0.9120732848784953,0,0,2
93,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.1655113682984142,3.768312943664099,6.77812250833505,"['CDKN1A', 'ABCB1']",0.9120732848784953,0,0,2
94,miR-517 relationship with ARCN1 and USP1 WP3596,0.1655113682984142,3.768312943664099,6.77812250833505,"['CDKN1A', 'ID2']",0.9120732848784953,0,0,2
95,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.1746131220440936,1.6495988495307297,2.878851017017474,"['LDHA', 'EDN1', 'ANGPT2', 'PKM', 'IGFBP3', 'PGK1', 'BAX']",0.9209861606759906,0,0,7
96,Myometrial relaxation and contraction pathways WP289,0.1750599272300448,1.2766087221713938,2.224652728580225,"['JUN', 'PRKCH', 'IGFBP5', 'YWHAB', 'IGFBP3', 'RGS16', 'PRKCD', 'ACTB', 'ACTG1', 'RGS4', 'RGS5', 'RGS2', 'GNG3', 'PRKAR1A', 'MAFF', 'CRH', 'CALM3', 'IGFBP6', 'CALM1', 'CALM2', 'YWHAG', 'CORIN', 'YWHAH']",0.9209861606759906,0,0,23
97,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.17579298713183844,1.4887149661329313,2.588053831897397,"['BEX3', 'CDKN1A', 'CASP7', 'CDKN1B', 'JUND', 'HSPA5', 'HSPB1', 'VIM', 'YBX3', 'ETS1']",0.9209861606759906,0,0,10
98,Synaptic Vesicle Pathway WP2267,0.17579298713183844,1.4887149661329313,2.588053831897397,"['RAB3A', 'SLC32A1', 'PARK7', 'SYN3', 'SLC25A4', 'CPLX1', 'SLC18A2', 'AP2M1', 'VAMP2', 'CPLX3']",0.9209861606759906,0,0,10
99,NRF2 pathway WP2884,0.17601859055390554,1.3231104814856527,2.2984620946422907,"['HSP90AA1', 'GPX2', 'TGFB1', 'HSP90AB1', 'ABCC2', 'SRXN1', 'GSTP1', 'SLC2A12', 'SLC39A11', 'SLC5A3', 'SLC2A9', 'DNAJB1', 'PRDX1', 'MAFF', 'SLC39A7', 'SLC39A3', 'CBR3', 'HSPA1A']",0.9209861606759906,0,0,18
100,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.18079869715498695,2.4228079264343996,4.1439005057114775,"['IDI1', 'HMGCS1', 'HMGCR']",0.9272646052107252,0,0,3
101,Nanoparticle triggered regulated necrosis WP2513,0.18079869715498695,2.4228079264343996,4.1439005057114775,"['CASP8', 'TRADD', 'FADD']",0.9272646052107252,0,0,3
102,Oxysterols derived from cholesterol WP4545,0.18644915608647034,1.6965047662278712,2.849443804492654,"['CYP39A1', 'DBP', 'INSIG1', 'ACOT11', 'DHCR7', 'ACOT6']",0.9468692436548198,0,0,6
103,Unfolded protein response WP4925,0.19889281028075337,1.7669578039927405,2.8536178430717594,"['XBP1', 'CASP8', 'HSPA5', 'DDIT3', 'TXNIP']",0.9999878479647376,0,0,5
104,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.20782054441624187,1.4543766233766233,2.2849425183548284,"['JUN', 'CD4', 'IL5', 'AHSA1', 'LCP2', 'PTPN6', 'CALM1', 'CALM2', 'CARD11']",0.9999878479647376,0,0,9
105,Kynurenine Pathway and links to Cellular Senescence WP5044,0.2114373106832986,1.8845049130763416,2.9281941026473124,"['CDKN1A', 'HAAO', 'KMO', 'ACMSD']",0.9999878479647376,0,0,4
106,Alanine and aspartate metabolism WP106,0.222366470147264,2.119786944696283,3.1869480889859156,"['GOT1', 'GAD1', 'ASL']",0.9999878479647376,0,0,3
107,Cancer immunotherapy by PD-1 blockade WP4585,0.222366470147264,2.119786944696283,3.1869480889859156,"['JUN', 'HLA-A', 'PDCD1LG2']",0.9999878479647376,0,0,3
108,Inflammatory Response Pathway WP453,0.222366470147264,2.119786944696283,3.1869480889859156,"['IL5', 'LAMB2', 'FN1']",0.9999878479647376,0,0,3
109,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.222366470147264,2.119786944696283,3.1869480889859156,"['PTTG1', 'ANAPC11', 'MAD2L1']",0.9999878479647376,0,0,3
110,Biogenic Amine Synthesis WP550,0.22444732541967194,2.8260081558676937,4.222378999713675,"['GAD1', 'PAH']",0.9999878479647376,0,0,2
111,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.22444732541967194,2.8260081558676937,4.222378999713675,"['SPI1', 'ID2']",0.9999878479647376,0,0,2
112,Irinotecan pathway WP229,0.22444732541967194,2.8260081558676937,4.222378999713675,"['ABCC2', 'CYP3A5']",0.9999878479647376,0,0,2
113,Methylation Pathways WP704,0.22444732541967194,2.8260081558676937,4.222378999713675,"['NNMT', 'MAT2B']",0.9999878479647376,0,0,2
114,Peroxiredoxin 2 induced ovarian failure WP4873,0.22444732541967194,2.8260081558676937,4.222378999713675,"['PRDX2', 'BAX']",0.9999878479647376,0,0,2
115,Urea cycle and related diseases WP4571,0.22444732541967194,2.8260081558676937,4.222378999713675,"['SLC25A15', 'ASL']",0.9999878479647376,0,0,2
116,7-oxo-C and 7beta-HC pathways WP5064,0.2277404024736791,1.662885662431942,2.4603206266536537,"['HSD11B1', 'DBP', 'ACOT11', 'DHCR7', 'ACOT6']",0.9999878479647376,0,0,5
117,Small cell lung cancer WP4658,0.2287586149271379,1.2749401103382723,1.8806487486650685,"['CDKN1C', 'CDKN1A', 'CDKN1B', 'LAMB3', 'GADD45B', 'LAMB2', 'GADD45A', 'LAMB4', 'FN1', 'CKS1B', 'CASP8', 'CCND1', 'CKS2', 'CYCS', 'BAX', 'SKP1']",0.9999878479647376,0,0,16
118,Proteasome Degradation WP183,0.23067326997423537,1.3525339241207421,1.9838331710404675,"['PSMD8', 'PSMD10', 'PSMB6', 'UBB', 'H2AFZ', 'H2AFX', 'UBC', 'HLA-B', 'HLA-A', 'PSMB10', 'HLA-E']",0.9999878479647376,0,0,11
119,Bladder cancer WP2828,0.24286228583415934,1.4659568742220876,2.074711183137618,"['CDKN1A', 'RPS6KA5', 'CCND1', 'EGF', 'DAPK2', 'HRAS', 'TYMP']",0.9999878479647376,0,0,7
120,Constitutive Androstane Receptor Pathway WP2875,0.2458817712178432,1.739403453689168,2.4402168688039843,"['HSP90AA1', 'ABCB1', 'ABCC2', 'CYP3A5']",0.9999878479647376,0,0,4
121,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.2458817712178432,1.739403453689168,2.4402168688039843,"['CYP26A1', 'ABCD2', 'ABCB1', 'ABCC2']",0.9999878479647376,0,0,4
122,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.2458817712178432,1.739403453689168,2.4402168688039843,"['GSK3A', 'ITGB4', 'BAX', 'BCL2L14']",0.9999878479647376,0,0,4
123,DNA Mismatch Repair WP531,0.2576996304603611,1.5703770921556766,2.129369456750742,"['PCNA', 'POLD1', 'RPA3', 'POLE2', 'POLE3']",0.9999878479647376,0,0,5
124,Sleep regulation WP3591,0.2576996304603611,1.5703770921556766,2.129369456750742,"['AHCY', 'ADORA2A', 'IL18', 'CRH', 'HCRTR2']",0.9999878479647376,0,0,5
125,Biomarkers for pyrimidine metabolism disorders WP4584,0.2655348485871466,1.8841039588999697,2.498339165292388,"['NT5C', 'CKB', 'TYMP']",0.9999878479647376,0,0,3
126,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.2655348485871466,1.8841039588999697,2.498339165292388,"['BMP2', 'SST', 'DKK1']",0.9999878479647376,0,0,3
127,Genes targeted by miRNAs in adipocytes WP1992,0.2655348485871466,1.8841039588999697,2.498339165292388,"['KCNE1', 'TMSB4X', 'KCNQ1']",0.9999878479647376,0,0,3
128,Hedgehog Signaling Pathway Netpath WP47,0.2655348485871466,1.8841039588999697,2.498339165292388,"['SAP18', 'GLI3', 'GLI2']",0.9999878479647376,0,0,3
129,IL1 and megakaryocytes in obesity WP2865,0.2655348485871466,1.8841039588999697,2.498339165292388,"['IL1R1', 'IL18', 'TIMP2']",0.9999878479647376,0,0,3
130,COVID-19 adverse outcome pathway WP4891,0.2781968596015128,5.650815217391305,7.229801536816514,['IL7'],0.9999878479647376,0,0,1
131,Methionine De Novo and Salvage Pathway WP3580,0.2814205484408128,1.6150307742144476,2.0477057791699282,"['AHCY', 'CHDH', 'ODC1', 'MAT2B']",0.9999878479647376,0,0,4
132,Nucleotide metabolism WP404,0.2814205484408128,1.6150307742144476,2.0477057791699282,"['PRPS1', 'POLD1', 'NME2', 'OAZ1']",0.9999878479647376,0,0,4
133,Purinergic signaling WP4900,0.2814205484408128,1.6150307742144476,2.0477057791699282,"['P2RY12', 'ADORA2A', 'LPAR6', 'P2RY14']",0.9999878479647376,0,0,4
134,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.28453864524436656,2.2606252831898503,2.841348719515065,"['CHI3L1', 'BAX']",0.9999878479647376,0,0,2
135,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.28453864524436656,2.2606252831898503,2.841348719515065,"['AHCY', 'MAT2B']",0.9999878479647376,0,0,2
136,NAD Biosynthesis II (from tryptophan) WP2485,0.28453864524436656,2.2606252831898503,2.841348719515065,"['HAAO', 'KMO']",0.9999878479647376,0,0,2
137,Sulfation Biotransformation Reaction WP692,0.28453864524436656,2.2606252831898503,2.841348719515065,"['SULT4A1', 'PAPSS2']",0.9999878479647376,0,0,2
138,Photodynamic therapy-induced unfolded protein response WP3613,0.288515219737084,1.4876062661190181,1.8491056561365293,"['XBP1', 'HSPA5', 'DDIT3', 'DNAJB9', 'CALR']",0.9999878479647376,0,0,5
139,DNA damage response WP707,0.28868319446852375,1.2850882632601597,1.5966263060217123,"['CDKN1A', 'CDKN1B', 'CASP8', 'CCND1', 'GADD45B', 'CDK5', 'GADD45A', 'H2AFX', 'CYCS', 'BAX']",0.9999878479647376,0,0,10
140,Folate Metabolism WP176,0.2923282610687961,1.3646371637069747,1.678337125175378,"['SERPINA3', 'GPX2', 'AHCY', 'GPX4', 'RFK', 'LDLR', 'SOD1']",0.9999878479647376,0,0,7
141,Adipogenesis WP236,0.3003713794817935,1.1869705776335946,1.427611815363739,"['CDKN1A', 'CEBPB', 'TGFB1', 'GADD45B', 'GADD45A', 'ASIP', 'EBF1', 'HMGA1', 'MIF', 'PRLR', 'SFRP4', 'CYP26A1', 'BMP2', 'DDIT3', 'NDN', 'ID3', 'PCK2']",0.9999878479647376,0,0,17
142,16p11.2 proximal deletion syndrome WP4949,0.30249362776229854,1.2337153970290065,1.4751474142869723,"['CASP8', 'PCNA', 'PPP2R1A', 'IGFBP3', 'TCP1', 'GDPD3', 'ALDOA', 'SEZ6L2', 'CCT7', 'CDIPT', 'YPEL3', 'CCT6B']",0.9999878479647376,0,0,12
143,Breast cancer pathway WP4262,0.3028175440177874,1.1661870740770395,1.3931560232278521,"['SHC4', 'JUN', 'CDKN1A', 'SHC3', 'GADD45B', 'GADD45A', 'EGF', 'TCF7', 'FGF1', 'DLL3', 'FGF17', 'SFRP4', 'FRAT1', 'FRAT2', 'CCND1', 'HEY1', 'CSNK2B', 'BAX', 'HRAS', 'SKP1']",0.9999878479647376,0,0,20
144,Matrix Metalloproteinases WP129,0.30954983062206465,1.6955575702629193,1.9882721796172664,"['MMP25', 'TIMP2', 'MMP21']",0.9999878479647376,0,0,3
145,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.31765658471025876,1.5072411186696901,1.7284806049931392,"['CASP7', 'CASP8', 'BAX', 'FADD']",0.9999878479647376,0,0,4
146,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.31765658471025876,1.5072411186696901,1.7284806049931392,"['JUN', 'ABCC2', 'SRXN1', 'GSTP1']",0.9999878479647376,0,0,4
147,Statin inhibition of cholesterol production WP430,0.31765658471025876,1.5072411186696901,1.7284806049931392,"['SQLE', 'HMGCR', 'LDLR', 'FDFT1']",0.9999878479647376,0,0,4
148,Alpha 6 Beta 4 signaling pathway WP244,0.31958224524275025,1.3566591012256015,1.547596143841356,"['LAMB3', 'ITGB4', 'LAMB2', 'PRKCD', 'GAB1', 'HRAS']",0.9999878479647376,0,0,6
149,Vitamin A and carotenoid metabolism WP716,0.31958224524275025,1.3566591012256015,1.547596143841356,"['CYP26A1', 'RBP4', 'RBP2', 'ALDH1A2', 'CRABP1', 'BCO1']",0.9999878479647376,0,0,6
150,Apoptosis Modulation and Signaling WP1772,0.32123179127391105,1.2115872293387087,1.3758691589940752,"['CASP7', 'JUN', 'CASP8', 'ENDOG', 'IL1R1', 'TRADD', 'PEA15', 'CYCS', 'BAX', 'FADD', 'PTPN13', 'HSPA1A']",0.9999878479647376,0,0,12
151,miRNA regulation of DNA damage response WP1530,0.33017798791442715,1.2290171421792515,1.3619026697429983,"['CDKN1A', 'CDKN1B', 'CASP8', 'CCND1', 'GADD45B', 'CDK5', 'GADD45A', 'H2AFX', 'CYCS', 'BAX']",0.9999878479647376,0,0,10
152,Androgen receptor signaling pathway WP138,0.3474452359395176,1.1640091116173121,1.2305301613589812,"['CDKN1A', 'JUN', 'RNF6', 'PARK7', 'ETV5', 'RHOB', 'CCND1', 'KAT5', 'PRDX1', 'BAG1', 'STUB1', 'CALR', 'FKBP4', 'RAN']",0.9999878479647376,0,0,14
153,Development of ureteric collection system WP5053,0.3480079940081597,1.3043751527637137,1.3768068808837488,"['CCND1', 'SPRY1', 'SLIT2', 'ETV4', 'GLI3', 'GLI2']",0.9999878479647376,0,0,6
154,Endothelin Pathways WP2197,0.3517181395343183,1.3457134214847464,1.4061698177857362,"['ADCY10', 'EDN1', 'NPY', 'CALM1', 'CALM2']",0.9999878479647376,0,0,5
155,Genes controlling nephrogenesis WP4823,0.3517181395343183,1.3457134214847464,1.4061698177857362,"['CXCL12', 'LAMB2', 'SLIT2', 'ETV4', 'GLI3']",0.9999878479647376,0,0,5
156,Differentiation of white and brown adipocyte WP2895,0.35374751269726545,1.5412923431962418,1.601667633077257,"['CEBPB', 'BMP2', 'ZIC1']",0.9999878479647376,0,0,3
157,Fatty acid transporters WP5061,0.35374751269726545,1.5412923431962418,1.601667633077257,"['FABP6', 'ACSL5', 'ACSBG2']",0.9999878479647376,0,0,3
158,GDNF/RET signaling axis WP4830,0.35374751269726545,1.5412923431962418,1.601667633077257,"['SPRY1', 'SLIT2', 'GLI3']",0.9999878479647376,0,0,3
159,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.35374751269726545,1.5412923431962418,1.601667633077257,"['TGFB1', 'FN1', 'VIM']",0.9999878479647376,0,0,3
160,TP53 network WP1742,0.35374751269726545,1.5412923431962418,1.601667633077257,"['CDKN1A', 'GADD45A', 'BAX']",0.9999878479647376,0,0,3
161,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.35421825393001455,1.4129251700680272,1.4663931116280842,"['GOT1', 'MDH2', 'SCO2', 'HMGA1']",0.9999878479647376,0,0,4
162,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.35421825393001455,1.4129251700680272,1.4663931116280842,"['GSK3A', 'PTPN6', 'CALM1', 'CALM2']",0.9999878479647376,0,0,4
163,G1 to S cell cycle control WP45,0.35726337875335745,1.2112987012987013,1.2467679663422762,"['CDKN1C', 'CDKN1A', 'CDKN1B', 'PCNA', 'CDKN2C', 'CCND1', 'GADD45A', 'RPA3', 'POLE2']",0.9999878479647376,0,0,9
164,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.36616593727495694,1.1189973363774735,1.124221563203392,"['VIPR1', 'JUN', 'CEBPB', 'TSPYL1', 'YWHAB', 'ATP1A3', 'SSTR1', 'ASCL1', 'PRKAR1A', 'SST', 'KCNQ1', 'PAH', 'TAC1', 'ALDOA', 'GAPDH', 'SLC25A4', 'YWHAG', 'VAMP2', 'YWHAH']",0.9999878479647376,0,0,19
165,Parkinson's disease pathway WP2371,0.3766333850456147,1.255964089373077,1.2264276046585192,"['CASP7', 'PINK1', 'UBB', 'CYCS', 'UBE2L6', 'PARK7']",0.9999878479647376,0,0,6
166,Oxidation by Cytochrome P450 WP43,0.3836326721768258,1.2844415113017653,1.2305845795667247,"['CYP39A1', 'CYP26A1', 'CYP3A5', 'CYP2C18', 'CYP3A7']",0.9999878479647376,0,0,5
167,Modulators of TCR signaling and T cell activation WP5072,0.3877412960064501,1.1898897630263756,1.1273216999161986,"['CDKN1B', 'NDUFB10', 'ELOB', 'LCP2', 'PTPN6', 'CD247', 'CARD11', 'ZFP36L1']",0.9999878479647376,0,0,8
168,Heart Development WP1591,0.39076540702850265,1.329705215419501,1.2494546881330197,"['BMP2', 'HEY1', 'VEGFB', 'VEGFC']",0.9999878479647376,0,0,4
169,Microglia Pathogen Phagocytosis Pathway WP3937,0.39076540702850265,1.329705215419501,1.2494546881330197,"['C1QB', 'C1QA', 'HCK', 'PTPN6']",0.9999878479647376,0,0,4
170,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.3941958716575014,1.1534927750090487,1.0737949105356117,"['CDKN1C', 'CDKN1A', 'CDKN1B', 'INF2', 'PCNA', 'TGFB1', 'ITGB4', 'LAMB2', 'VIM', 'DKK1']",0.9999878479647376,0,0,10
171,IL-3 signaling pathway WP286,0.3961330825637895,1.198841273773154,1.1101330821804671,"['HCK', 'JUN', 'TGFB1', 'YWHAB', 'IL3RA', 'PTPN6', 'HRAS']",0.9999878479647376,0,0,7
172,EDA signaling in hair follicle development WP3930,0.4019462244717506,1.6144734287008868,1.4714907688412717,"['LTB', 'DKK1']",0.9999878479647376,0,0,2
173,DNA Replication WP466,0.4052986123019829,1.2110109590817717,1.0937017434287541,"['PCNA', 'POLD1', 'RPA3', 'POLE2', 'UBC', 'UBA52']",0.9999878479647376,0,0,6
174,Endochondral Ossification with Skeletal Dysplasias WP4808,0.4120963245595203,1.159286571371987,1.0277054118362672,"['CDKN1C', 'GHR', 'TGFB1', 'HMGCS1', 'SPP1', 'CALM1', 'CALM2', 'GLI3']",0.9999878479647376,0,0,8
175,Endochondral Ossification WP474,0.4120963245595203,1.159286571371987,1.0277054118362672,"['CDKN1C', 'GHR', 'TGFB1', 'HMGCS1', 'SPP1', 'CALM1', 'CALM2', 'GLI3']",0.9999878479647376,0,0,8
176,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.4255891499272102,1.1302727272727273,0.9655703290873163,"['CDKN1A', 'JUN', 'CDKN1B', 'TMSB4X', 'FN1', 'PFN4', 'NEFH', 'PFN2', 'SOD1']",0.9999878479647376,0,0,9
177,Physiological and pathological hypertrophy of the heart WP1528,0.42699317346966087,1.255731922398589,1.0686118592365446,"['EDN1', 'JUN', 'CALM1', 'CALM2']",0.9999878479647376,0,0,4
178,Calcium Regulation in the Cardiac Cell WP536,0.43426323332268035,1.066395442047286,0.8894851307274516,"['PRKCH', 'YWHAB', 'RGS16', 'CHRM5', 'PRKCD', 'ATP1B1', 'RGS4', 'GJD2', 'RGS5', 'RGS2', 'GNG3', 'PLN', 'PRKAR1A', 'GJA9', 'CALM3', 'CALR', 'CALM1', 'CALM2', 'YWHAG', 'YWHAH']",0.9999878479647376,0,0,20
179,Metapathway biotransformation Phase I and II WP702,0.4361424680033236,1.076498816580896,0.8932639996037374,"['CHST9', 'GPX2', 'NNMT', 'GPX4', 'GSTP1', 'KCNAB1', 'GLYAT', 'CYP2C18', 'CYP3A5', 'FMO5', 'CYP3A7', 'CYP39A1', 'CYP26A1', 'NAT8L', 'SULT4A1', 'CHST2']",0.9999878479647376,0,0,16
180,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.43641113578793017,1.130213539300318,0.9371397344863005,"['CDKN1A', 'CEBPB', 'BMP2', 'TGFB1', 'MSTN', 'TCF7', 'SPP1', 'ACTB']",0.9999878479647376,0,0,8
181,Endometrial cancer WP4155,0.43726898819665905,1.1080794300439594,0.9166107725654008,"['CDKN1A', 'CCND1', 'GADD45B', 'EGF', 'GADD45A', 'TCF7', 'BAX', 'CTNNA3', 'FGF1', 'HRAS']",0.9999878479647376,0,0,10
182,miRNA targets in ECM and membrane receptors WP2911,0.4405103087058057,1.3039612246321222,1.0690153579241073,"['TNXB', 'LAMB2', 'FN1']",0.9999878479647376,0,0,3
183,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.4405103087058057,1.3039612246321222,1.0690153579241073,"['BMP2', 'TGFB1', 'FN1']",0.9999878479647376,0,0,3
184,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.4405103087058057,1.3039612246321222,1.0690153579241073,"['HMGCS1', 'HMGCR', 'LDLR']",0.9999878479647376,0,0,3
185,Differentiation Pathway WP2848,0.4470191062864823,1.1772156684815487,0.9478398359582931,"['TGFB1', 'EGF', 'FST', 'FGF1', 'DKK1']",0.9999878479647376,0,0,5
186,Prion disease pathway WP3995,0.4470191062864823,1.1772156684815487,0.9478398359582931,"['PRNP', 'SPI1', 'HSPA5', 'RFX5', 'EBF1']",0.9999878479647376,0,0,5
187,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.4484682013673039,1.1301544050862853,0.9062905950935697,"['IDI1', 'SQLE', 'HMGCS1', 'MSMO1', 'HMGCR', 'DHCR7', 'FDFT1']",0.9999878479647376,0,0,7
188,Dopamine metabolism WP2436,0.4572330831623902,1.4125509741730857,1.1054087003459858,"['TYR', 'SOD1']",0.9999878479647376,0,0,2
189,miR-509-3p alteration of YAP1/ECM axis WP3967,0.4572330831623902,1.4125509741730857,1.1054087003459858,"['YAP1', 'FN1']",0.9999878479647376,0,0,2
190,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.4572330831623902,1.4125509741730857,1.1054087003459858,"['JUN', 'TIFA']",0.9999878479647376,0,0,2
191,Transcriptional cascade regulating adipogenesis WP4211,0.4572330831623902,1.4125509741730857,1.1054087003459858,"['CEBPB', 'DDIT3']",0.9999878479647376,0,0,2
192,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.4587303383939079,1.0866827578969462,0.8468439834978975,"['SFRP4', 'FRAT1', 'JUN', 'FRAT2', 'CCND1', 'CSNK2B', 'TCF7', 'NOTUM', 'DKK1', 'CXXC4']",0.9999878479647376,0,0,10
193,G13 Signaling Pathway WP524,0.46215843078322416,1.1300953245574217,0.8722612769141963,"['CFL2', 'CFL1', 'ARHGDIG', 'WAS', 'CALM1', 'CALM2']",0.9999878479647376,0,0,6
194,Hedgehog Signaling Pathway WP4249,0.46215843078322416,1.1300953245574217,0.8722612769141963,"['EVC', 'CCND1', 'HHIP', 'GAS1', 'GLI3', 'GLI2']",0.9999878479647376,0,0,6
195,Cells and molecules involved in local acute inflammatory response  WP4493,0.4790253515132347,1.8833031400966183,1.3861144201818008,['C6'],0.9999878479647376,0,0,1
196,Composition of Lipid Particles WP3601,0.4790253515132347,1.8833031400966183,1.3861144201818008,['LDLR'],0.9999878479647376,0,0,1
197,Platelet-mediated interactions with vascular and circulating cells WP4462,0.4790253515132347,1.8833031400966183,1.3861144201818008,['TGFB1'],0.9999878479647376,0,0,1
198,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.4790253515132347,1.8833031400966183,1.3861144201818008,['SLIT2'],0.9999878479647376,0,0,1
199,Vitamin B6-dependent and responsive disorders WP4228,0.4790253515132347,1.8833031400966183,1.3861144201818008,['PNPO'],0.9999878479647376,0,0,1
200,Melanoma WP4685,0.48006119677501735,1.0660935073403863,0.7823438610452639,"['CDKN1A', 'CCND1', 'GADD45B', 'GADD45A', 'BAX', 'CALM3', 'CALM1', 'ETS1', 'HRAS', 'CALM2']",0.9999878479647376,0,0,10
201,"GPCRs, Class B Secretin-like WP334",0.48221640489852313,1.2107239994819323,0.8830564322962865,"['VIPR1', 'CALCR', 'ADGRG2']",0.9999878479647376,0,0,3
202,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.48221640489852313,1.2107239994819323,0.8830564322962865,"['EIF1AX', 'EIF3I', 'EIF1']",0.9999878479647376,0,0,3
203,Nephrotic syndrome WP4758,0.49008622043541594,1.0935527799335218,0.7798933482547473,"['CUBN', 'INF2', 'ITGB4', 'LAMB2', 'PMM2', 'EMP2']",0.9999878479647376,0,0,6
204,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.49008622043541594,1.0935527799335218,0.7798933482547473,"['CASP8', 'TGFB1', 'CXCL12', 'TRADD', 'CXCL17', 'FADD']",0.9999878479647376,0,0,6
205,Vitamin B12 metabolism WP1533,0.4974576255950868,1.1299773242630387,0.7890009045668579,"['SERPINA3', 'CUBN', 'LDLR', 'SOD1']",0.9999878479647376,0,0,4
206,Cysteine and methionine catabolism WP4504,0.5094256364718291,1.2555001762070181,0.8467989501256978,"['AHCY', 'GOT1']",0.9999878479647376,0,0,2
207,Glutathione metabolism WP100,0.5094256364718291,1.2555001762070181,0.8467989501256978,"['GPX2', 'GPX4']",0.9999878479647376,0,0,2
208,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.5094256364718291,1.2555001762070181,0.8467989501256978,"['TGFB1', 'CCND1']",0.9999878479647376,0,0,2
209,RalA downstream regulated genes WP2290,0.5094256364718291,1.2555001762070181,0.8467989501256978,"['YBX3', 'HRAS']",0.9999878479647376,0,0,2
210,Serotonin and anxiety-related events WP3944,0.5094256364718291,1.2555001762070181,0.8467989501256978,"['ARC', 'CRH']",0.9999878479647376,0,0,2
211,Copper homeostasis WP3286,0.5250345122661876,1.040680720875759,0.670501514662286,"['PRNP', 'JUN', 'CCND1', 'SCO2', 'COX17', 'ATOX1', 'SOD1']",0.9999878479647376,0,0,7
212,Prader-Willi and Angelman Syndrome WP3998,0.5250345122661876,1.040680720875759,0.670501514662286,"['GABRR2', 'MAGEL2', 'CDKN2C', 'CCND1', 'DLX5', 'NDN', 'TYR']",0.9999878479647376,0,0,7
213,Alzheimer's disease WP2059,0.528032455897502,1.018712987962231,0.6505475955100566,"['PSENEN', 'ATP5MD', 'CASP7', 'CASP8', 'CDK5', 'CYCS', 'CALM3', 'FADD', 'CALM1', 'GAPDH', 'CALM2']",0.9999878479647376,0,0,11
214,Glycosylation and related congenital defects WP4521,0.5312713175554103,1.0760824964906597,0.6806032748278287,"['DPM3', 'MPI', 'PMM2', 'DOLK']",0.9999878479647376,0,0,4
215,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.5312713175554103,1.0760824964906597,0.6806032748278287,"['RAB3B', 'RAB3A', 'HSPB1', 'RABAC1']",0.9999878479647376,0,0,4
216,T-cell receptor (TCR) signaling pathway WP69,0.5427235106119283,1.0087377379328266,0.616495391937917,"['JUN', 'CD4', 'TGFB1', 'PRKCD', 'WAS', 'LCP2', 'CD247', 'VIM', 'HRAS', 'CARD11']",0.9999878479647376,0,0,10
217,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.5574037951841118,1.4123641304347827,0.8254779032101428,['CYP2C18'],0.9999878479647376,0,0,1
218,Metabolism of alpha-linolenic acid WP4586,0.5574037951841118,1.4123641304347827,0.8254779032101428,['ALOX12'],0.9999878479647376,0,0,1
219,Mitochondrial fatty acid synthesis pathway WP4317,0.5574037951841118,1.4123641304347827,0.8254779032101428,['HSD17B12'],0.9999878479647376,0,0,1
220,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.5574037951841118,1.4123641304347827,0.8254779032101428,['DLL3'],0.9999878479647376,0,0,1
221,Tgif disruption of Shh signaling WP3674,0.5574037951841118,1.4123641304347827,0.8254779032101428,['GLI3'],0.9999878479647376,0,0,1
222,Vitamin D Metabolism WP1531,0.5574037951841118,1.4123641304347827,0.8254779032101428,['DHCR7'],0.9999878479647376,0,0,1
223,Overview of nanoparticle effects WP3287,0.5582037632876693,1.129859537834164,0.6587433803384428,"['FN1', 'BAX']",0.9999878479647376,0,0,2
224,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5630029576467269,0.990960803555045,0.5692776467125823,"['CDKN1A', 'JUN', 'TGFB1', 'CCND1', 'GADD45B', 'GADD45A', 'TCF7', 'CYCS', 'BAX', 'NTN1']",0.9999878479647376,0,0,10
225,Tryptophan metabolism WP465,0.5639173302979641,1.02708719851577,0.5883644527996037,"['HAAO', 'ALDH1A2', 'CYP2C18', 'ACMSD']",0.9999878479647376,0,0,4
226,PI3K-Akt signaling pathway WP4172,0.5645566467527621,0.983342258349467,0.5621910785804491,"['CDKN1A', 'CDKN1B', 'TNXB', 'HSP90AB1', 'ITGB4', 'FGF1', 'GYS2', 'GHR', 'GNG3', 'CCND1', 'PPP2R1A', 'NTF3', 'SPP1', 'HRAS', 'PCK2', 'HSP90AA1', 'ANGPT2', 'LAMB3', 'EGF', 'LAMB2', 'LAMB4', 'FN1', 'VEGFB', 'VEGFC', 'PRLR', 'EPOR', 'FGF17', 'EFNA3', 'LPAR6', 'IL7', 'DDIT4', 'IL3RA', 'ITGA5', 'FGFR4', 'SGK2']",0.9999878479647376,0,0,35
227,Pathways in clear cell renal cell carcinoma WP4018,0.5668551368270012,0.9862140185161113,0.5598258654549474,"['LDHA', 'TPI1', 'PKM', 'TGFB1', 'PGK1', 'ALDOC', 'ENO1', 'ENO2', 'ALDOA', 'GAPDH', 'ACACB']",0.9999878479647376,0,0,11
228,p38 MAPK Signaling Pathway WP400,0.567223426547962,1.008717915478351,0.5719450780567437,"['RPS6KA5', 'TRADD', 'DDIT3', 'HSPB1', 'HRAS']",0.9999878479647376,0,0,5
229,One-carbon metabolism and related pathways WP3940,0.5705216525181928,0.9968225147526101,0.5594209388897529,"['GPX2', 'GPX4', 'CHDH', 'GAD1', 'PLD1', 'SOD1']",0.9999878479647376,0,0,6
230,TGF-beta Receptor Signaling WP560,0.5705216525181928,0.9968225147526101,0.5594209388897529,"['JUN', 'TGFB1', 'EGF', 'FST', 'SPP1', 'HRAS']",0.9999878479647376,0,0,6
231,Genotoxicity pathway WP4286,0.573753453564363,0.9884877384196186,0.549159798121882,"['PLK3', 'CDKN1A', 'RPS27', 'GADD45A', 'ID2', 'TRIAP1', 'PHLDA3']",0.9999878479647376,0,0,7
232,Focal Adhesion WP306,0.5791158578486832,0.9750456842763775,0.5326213586375131,"['SHC4', 'JUN', 'TNXB', 'SHC3', 'LAMB3', 'ITGB4', 'EGF', 'LAMB2', 'TXK', 'FN1', 'VEGFB', 'TESK2', 'VEGFC', 'ACTB', 'MYL12B', 'ACTG1', 'MYLPF', 'HCK', 'PPP1CC', 'CCND1', 'SPP1', 'FLNC', 'ITGA5', 'HRAS']",0.9999878479647376,0,0,24
233,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.5951414798982624,0.973856311408724,0.5053886931571536,"['IFITM3', 'JUN', 'IFITM2', 'IFI27', 'DDIT3']",0.9999878479647376,0,0,5
234,Cardiac Progenitor Differentiation WP2406,0.5952711628268686,0.9823523612343488,0.509583736310753,"['MESP1', 'TGFB1', 'THY1', 'DKK1']",0.9999878479647376,0,0,4
235,Phosphodiesterases in neuronal function WP4222,0.5972021275412198,0.9643007465496999,0.4970966981089699,"['ADCY10', 'PDE10A', 'ADORA2A', 'PDE6C', 'PDE5A', 'PDE6B', 'PDE9A']",0.9999878479647376,0,0,7
236,Striated Muscle Contraction Pathway WP383,0.5972089156219756,0.9968268359020852,0.5138525554728104,"['MYOM1', 'VIM', 'ACTG1']",0.9999878479647376,0,0,3
237,Oncostatin M Signaling Pathway WP2374,0.5987782986363648,0.9613425232244531,0.49303784542947615,"['CASP7', 'CEBPB', 'CDKN1B', 'PRKCH', 'JUND', 'PRKCD', 'HRAS', 'LDLR']",0.9999878479647376,0,0,8
238,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.6023939146119522,0.9572147586345103,0.4851582742236556,"['SFRP4', 'FRAT1', 'JUN', 'FRAT2', 'CCND1', 'CSNK2B', 'TCF7', 'NOTUM', 'DKK1', 'CXXC4']",0.9999878479647376,0,0,10
239,Airway smooth muscle cell contraction WP4962,0.6034135357526272,1.027062651892738,0.518823286840939,"['CALM1', 'CALM2']",0.9999878479647376,0,0,2
240,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.6034135357526272,1.027062651892738,0.518823286840939,"['CCND1', 'TULP3']",0.9999878479647376,0,0,2
241,Major receptors targeted by epinephrine and norepinephrine WP4589,0.6034135357526272,1.027062651892738,0.518823286840939,"['ADCY10', 'ADRA2C']",0.9999878479647376,0,0,2
242,Phytochemical activity on NRF2 transcriptional activation WP3,0.6034135357526272,1.027062651892738,0.518823286840939,"['AIMP2', 'CEBPB']",0.9999878479647376,0,0,2
243,Pyrimidine metabolism and related diseases WP4225,0.6034135357526272,1.027062651892738,0.518823286840939,"['NT5C', 'TYMP']",0.9999878479647376,0,0,2
244,Tryptophan catabolism leading to NAD+ production WP4210,0.6034135357526272,1.027062651892738,0.518823286840939,"['HAAO', 'KMO']",0.9999878479647376,0,0,2
245,Eukaryotic Transcription Initiation WP405,0.6204957499315592,0.9412921773339386,0.4492190065780867,"['TAF13', 'POLR2E', 'TAF7', 'POLR2I', 'POLR3K', 'POLR2K']",0.9999878479647376,0,0,6
246,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.6204957499315592,0.9412921773339386,0.4492190065780867,"['CCNA2', 'CDKN1A', 'HSP90AA1', 'JUN', 'CCND1', 'BAX']",0.9999878479647376,0,0,6
247,Apoptosis WP254,0.620610602184746,0.9412121212121212,0.4490066009213286,"['CASP7', 'JUN', 'CASP8', 'TRADD', 'IRF1', 'CYCS', 'BAX', 'FADD', 'NFKBIE']",0.9999878479647376,0,0,9
248,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6220228055147727,0.941318814277072,0.4469179554677205,"['MAP1LC3A', 'MSTN', 'IGFBP5', 'TNFSF9', 'PLD1']",0.9999878479647376,0,0,5
249,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.6239950341623114,1.129800724637681,0.5328285608255932,['SPI1'],0.9999878479647376,0,0,1
250,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.6239950341623114,1.129800724637681,0.5328285608255932,['HSD11B1'],0.9999878479647376,0,0,1
251,miRNA Biogenesis WP2338,0.6239950341623114,1.129800724637681,0.5328285608255932,['RAN'],0.9999878479647376,0,0,1
252,Osteoblast Signaling WP322,0.6239950341623114,1.129800724637681,0.5328285608255932,['BGLAP'],0.9999878479647376,0,0,1
253,Tamoxifen metabolism WP691,0.6239950341623114,1.129800724637681,0.5328285608255932,['CYP3A5'],0.9999878479647376,0,0,1
254,The influence of laminopathies on Wnt signaling WP4844,0.6252388264141852,0.9413454270597128,0.44207612675628916,"['CEBPB', 'CCND1', 'TCF7', 'SPP1']",0.9999878479647376,0,0,4
255,Gastric Cancer Network 1 WP2361,0.6316161398810438,0.9413720157147174,0.43253544117350173,"['H3F3A', 'GATD3A', 'KIF15']",0.9999878479647376,0,0,3
256,IL-7 signaling pathway WP205,0.6316161398810438,0.9413720157147174,0.43253544117350173,"['CDKN1B', 'CCND1', 'IL7']",0.9999878479647376,0,0,3
257,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.6316161398810438,0.9413720157147174,0.43253544117350173,"['BMP2', 'ASCL1', 'GLI2']",0.9999878479647376,0,0,3
258,Non-small cell lung cancer WP4255,0.6399962871965623,0.9256815691186009,0.4131251155692212,"['CDKN1A', 'CASP8', 'CCND1', 'GADD45B', 'EGF', 'GADD45A', 'CRABP1', 'CYCS', 'BAX', 'HRAS']",0.9999878479647376,0,0,10
259,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6420110721409641,0.9193016919079906,0.40738829574435753,"['IFI27L2', 'JUN', 'PRKCH', 'PRKCD', 'ISG15', 'ETS1', 'HRAS']",0.9999878479647376,0,0,7
260,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.6441957344041103,0.9157782385199543,0.40271591969881854,"['PPP1CC', 'PPP1R14B', 'XBP1', 'MAP1LC3A', 'HSPA5', 'DDIT3']",0.9999878479647376,0,0,6
261,Serotonin and anxiety WP3947,0.6450245039482457,0.941398580274883,0.4127721852117545,"['ARC', 'CRH']",0.9999878479647376,0,0,2
262,Type II diabetes mellitus WP1584,0.6450245039482457,0.941398580274883,0.4127721852117545,"['KCNJ11', 'PRKCD']",0.9999878479647376,0,0,2
263,Hepatitis C and Hepatocellular Carcinoma WP3646,0.6478073620153465,0.9108805105087524,0.3954696200992487,"['CDKN1A', 'CASP7', 'JUN', 'TGFB1', 'CCND1']",0.9999878479647376,0,0,5
264,Melatonin metabolism and effects WP3298,0.6537539582422611,0.9036190476190477,0.3840599709052265,"['PER2', 'EDN1', 'CALM1', 'CALM2']",0.9999878479647376,0,0,4
265,Tumor suppressor activity of SMARCB1 WP4204,0.6537539582422611,0.9036190476190477,0.3840599709052265,"['H3F3B', 'H3F3A', 'GLI3', 'GLI2']",0.9999878479647376,0,0,4
266,B Cell Receptor Signaling Pathway WP23,0.6574397230804254,0.9133303002729755,0.383052732745659,"['JUN', 'GSK3A', 'CD81', 'PRKCD', 'GAB1', 'PTPN6', 'ETS1', 'ILF2', 'HRAS', 'CARD11', 'RASGRP3']",0.9999878479647376,0,0,11
267,Retinoblastoma gene in cancer WP2446,0.658054956981489,0.9106778741069987,0.38108848303404047,"['CCNA2', 'CDKN1A', 'CDKN1B', 'PCNA', 'CCND1', 'H2AFZ', 'KIF4A', 'RPA3', 'POLE2', 'DCK']",0.9999878479647376,0,0,10
268,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.6591204746709027,0.9074512987012987,0.3782701181509132,"['IDI1', 'SQLE', 'GSK3A', 'RBP4', 'HMGCS1', 'INSIG1', 'HMGCR', 'LDLR', 'FDFT1']",0.9999878479647376,0,0,9
269,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.6639250007970908,0.8917545450207568,0.3652502542064115,"['CEBPB', 'CCND1', 'PRLR']",0.9999878479647376,0,0,3
270,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.666979654708164,0.8916071385909167,0.3610970895109779,"['JUN', 'TGFB1', 'EGF', 'FST', 'SPP1', 'HRAS']",0.9999878479647376,0,0,6
271,TNF-alpha signaling pathway WP231,0.6742298323924147,0.9000210995503158,0.35477412283326465,"['CASP7', 'HSP90AA1', 'JUN', 'CASP8', 'TRADD', 'RFK', 'BAX', 'FADD', 'NFKBIE', 'HRAS', 'SKP1']",0.9999878479647376,0,0,11
272,"Cerebral organic acidurias, including diseases WP4519",0.680571042253919,0.9414251207729468,0.3622821006315604,['MDH2'],0.9999878479647376,0,0,1
273,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.680571042253919,0.9414251207729468,0.3622821006315604,['DHCR7'],0.9999878479647376,0,0,1
274,Estrogen metabolism WP697,0.680571042253919,0.9414251207729468,0.3622821006315604,['ARSD'],0.9999878479647376,0,0,1
275,Glucuronidation WP698,0.680571042253919,0.9414251207729468,0.3622821006315604,['PGM5'],0.9999878479647376,0,0,1
276,Role of Osx and miRNAs in tooth development WP3971,0.680571042253919,0.9414251207729468,0.3622821006315604,['DKK1'],0.9999878479647376,0,0,1
277,Serotonin Transporter Activity WP1455,0.680571042253919,0.9414251207729468,0.3622821006315604,['IL1R1'],0.9999878479647376,0,0,1
278,CAMKK2  Pathway WP4874,0.6807748239152179,0.8687946973661259,0.33407213641529704,"['FIS1', 'MAP1LC3A', 'CALM1', 'CALM2']",0.9999878479647376,0,0,4
279,Eicosanoid Synthesis WP167,0.6830960617178409,0.8689135965982364,0.3311601610070629,"['PTGES2', 'ALOX12']",0.9999878479647376,0,0,2
280,Aryl Hydrocarbon Receptor Netpath WP2586,0.6959253981748609,0.8555381400208987,0.3101435359907909,"['CDKN1A', 'HSP90AA1', 'CDKN1B', 'AIP', 'HRAS']",0.9999878479647376,0,0,5
281,IL-6 signaling pathway WP364,0.6959253981748609,0.8555381400208987,0.3101435359907909,"['HCK', 'IRF1', 'PRKCD', 'GAB1', 'VIP']",0.9999878479647376,0,0,5
282,Integrated Cancer Pathway WP1971,0.6959253981748609,0.8555381400208987,0.3101435359907909,"['CDKN1A', 'CDKN1B', 'CASP8', 'BAX', 'BACH1']",0.9999878479647376,0,0,5
283,BDNF-TrkB Signaling WP3676,0.7062813151905328,0.8365499286134207,0.29090325868366135,"['ARC', 'TRPC3', 'GAB1', 'HRAS']",0.9999878479647376,0,0,4
284,miRNA regulation of prostate cancer signaling pathways WP3981,0.7062813151905328,0.8365499286134207,0.29090325868366135,"['CDKN1A', 'CDKN1B', 'CCND1', 'TCF7']",0.9999878479647376,0,0,4
285,Transcription factor regulation in adipogenesis WP3599,0.7177511304404474,0.8067836105896822,0.2675555729621729,"['CEBPB', 'PCK2']",0.9999878479647376,0,0,2
286,Common Pathways Underlying Drug Addiction WP2636,0.7182139079552539,0.8303085299455535,0.2748220205171886,"['PPP1CC', 'CALM1', 'CALM2', 'ACTB', 'ACTG1']",0.9999878479647376,0,0,5
287,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.7222130345711388,0.8066960238311099,0.26252721883444613,"['CCND1', 'FGF1', 'GLI2']",0.9999878479647376,0,0,3
288,Monoamine GPCRs WP58,0.7222130345711388,0.8066960238311099,0.26252721883444613,"['CHRM5', 'HTR2B', 'ADRA2C']",0.9999878479647376,0,0,3
289,Canonical NF-KB pathway WP4562,0.7286375148591224,0.8068711180124224,0.2554383764440557,['NFKBIE'],0.9999878479647376,0,0,1
290,"Degradation pathway of sphingolipids, including diseases WP4153",0.7286375148591224,0.8068711180124224,0.2554383764440557,['NEU1'],0.9999878479647376,0,0,1
291,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.7286375148591224,0.8068711180124224,0.2554383764440557,['CEBPB'],0.9999878479647376,0,0,1
292,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.7286375148591224,0.8068711180124224,0.2554383764440557,['ELOB'],0.9999878479647376,0,0,1
293,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.7286375148591224,0.8068711180124224,0.2554383764440557,['TIFA'],0.9999878479647376,0,0,1
294,Leptin and adiponectin WP3934,0.7286375148591224,0.8068711180124224,0.2554383764440557,['LEPR'],0.9999878479647376,0,0,1
295,Mitochondrial CII Assembly WP4920,0.7286375148591224,0.8068711180124224,0.2554383764440557,['SDHAF1'],0.9999878479647376,0,0,1
296,Nephrogenesis WP5052,0.7286375148591224,0.8068711180124224,0.2554383764440557,['ALDH1A2'],0.9999878479647376,0,0,1
297,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.7286375148591224,0.8068711180124224,0.2554383764440557,['TGFB1'],0.9999878479647376,0,0,1
298,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.7339477721690261,0.8362528816867754,0.2586675737811118,"['JUN', 'CDKN1B', 'PAX8', 'APEX1', 'PLD1', 'HRAS', 'TSHR', 'MYL12B']",0.9999878479647376,0,0,8
299,Glioblastoma signaling pathways WP2261,0.7401555640954185,0.8423774714422431,0.2534670792420815,"['CDKN1A', 'CDKN1B', 'PRKCH', 'CDKN2C', 'CCND1', 'PRKCD', 'GAB1', 'SPRY2', 'FOXO4', 'HRAS']",0.9999878479647376,0,0,10
300,AGE/RAGE pathway WP2324,0.7403162477468201,0.8232099606418407,0.2475209782260164,"['MSR1', 'JUN', 'CASP8', 'PRKCD', 'CYCS', 'FOXO4', 'SOD1']",0.9999878479647376,0,0,7
301,Oxidative Stress WP408,0.748250509749784,0.7699662078628534,0.22330363695558145,"['NOX3', 'TXN2', 'SOD1']",0.9999878479647376,0,0,3
302,Signal transduction through IL1R WP4496,0.748250509749784,0.7699662078628534,0.22330363695558145,"['JUN', 'TGFB1', 'IL1R1']",0.9999878479647376,0,0,3
303,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.7485685270589021,0.8919013886546354,0.25828797679355925,"['CDKN1A', 'CDKN1B', 'TNXB', 'HSP90AB1', 'ITGB4', 'HIF3A', 'FGF1', 'GYS2', 'GHR', 'GNG3', 'PPP2R1A', 'SPP1', 'PELO', 'HRAS', 'HSP90AA1', 'ANGPT2', 'LAMB3', 'EGF', 'LAMB2', 'FN1', 'VEGFB', 'VEGFC', 'PRLR', 'EPOR', 'FGF17', 'EFNA3', 'LPAR6', 'DDIT4', 'IL3RA', 'ITGA5', 'FGFR4']",0.9999878479647376,0,0,31
304,Ebstein-Barr virus LMP1 signaling WP262,0.7491557204128002,0.7529376227156018,0.21745471964177288,"['HSP90AA1', 'TRADD']",0.9999878479647376,0,0,2
305,Nicotine Activity on Dopaminergic Neurons WP1602,0.7491557204128002,0.7529376227156018,0.21745471964177288,"['CDK5', 'SLC18A2']",0.9999878479647376,0,0,2
306,Proteoglycan biosynthesis WP4784,0.7491557204128002,0.7529376227156018,0.21745471964177288,"['B4GALT7', 'PAPSS2']",0.9999878479647376,0,0,2
307,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.752761460426628,0.7787317225740871,0.2211651723297295,"['CASP7', 'JUN', 'CASP8', 'FADD']",0.9999878479647376,0,0,4
308,15q11.2 copy number variation syndrome WP4940,0.7694738674591532,0.7059556159420289,0.18499445964161118,['TUBGCP4'],0.9999878479647376,0,0,1
309,Biotin Metabolism (including IEMs) WP5031,0.7694738674591532,0.7059556159420289,0.18499445964161118,['ACACB'],0.9999878479647376,0,0,1
310,Estrogen Receptor Pathway WP2881,0.7694738674591532,0.7059556159420289,0.18499445964161118,['JUN'],0.9999878479647376,0,0,1
311,Purine metabolism WP4792,0.7694738674591532,0.7059556159420289,0.18499445964161118,['PRPS1'],0.9999878479647376,0,0,1
312,Vitamin B12 Disorders WP4271,0.7694738674591532,0.7059556159420289,0.18499445964161118,['CUBN'],0.9999878479647376,0,0,1
313,Ethanol effects on histone modifications WP3996,0.7722939355138767,0.7364302889353147,0.19028626355260525,"['AHCY', 'ALDH1A2', 'HAT1']",0.9999878479647376,0,0,3
314,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.7722939355138767,0.7364302889353147,0.19028626355260525,"['TGFB1', 'MFGE8', 'HRAS']",0.9999878479647376,0,0,3
315,One-carbon metabolism WP241,0.7722939355138767,0.7364302889353147,0.19028626355260525,"['AHCY', 'CHDH', 'MAT2B']",0.9999878479647376,0,0,3
316,White fat cell differentiation WP4149,0.7722939355138767,0.7364302889353147,0.19028626355260525,"['CEBPB', 'DDIT3', 'EBF1']",0.9999878479647376,0,0,3
317,ATM Signaling Pathway WP2516,0.7737774305176393,0.752713529856387,0.19304919488904002,"['CDKN1A', 'JUN', 'GADD45A', 'H2AFX']",0.9999878479647376,0,0,4
318,Target Of Rapamycin (TOR) Signaling WP1471,0.7737774305176393,0.752713529856387,0.19304919488904002,"['IDI1', 'RRAGA', 'DDIT4', 'HMGCR']",0.9999878479647376,0,0,4
319,"Relationship between inflammation, COX-2 and EGFR WP4483",0.7775032001736987,0.7058223833257816,0.17763256803675231,"['PTGES2', 'HRAS']",0.9999878479647376,0,0,2
320,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.7775032001736987,0.7058223833257816,0.17763256803675231,"['MDH2', 'IDH3B']",0.9999878479647376,0,0,2
321,Wnt signaling pathway and pluripotency WP399,0.7825120622112178,0.8060806860261157,0.19768801694696025,"['FRAT1', 'JUN', 'PRKCH', 'CCND1', 'PPP2R1A', 'PRKCD', 'TCF7', 'ESRRB', 'ZBTB33', 'LDLR']",0.9999878479647376,0,0,10
322,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.7893517979623713,0.7745988495307297,0.1832260744967823,"['ITGB4', 'TCF7', 'CTNNA3', 'ITGA5', 'ACTB', 'SGCG', 'ACTG1']",0.9999878479647376,0,0,7
323,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7893517979623713,0.7745988495307297,0.1832260744967823,"['YAP1', 'CASP7', 'ANGPT2', 'FN1', 'BAX', 'HRAS', 'ANGPTL1']",0.9999878479647376,0,0,7
324,Wnt signaling WP428,0.7901370248170423,0.8059924606785389,0.1898506370585926,"['SFRP4', 'FRAT1', 'JUN', 'FRAT2', 'CCND1', 'CSNK2B', 'TCF7', 'GPC4', 'NOTUM', 'DKK1', 'CXXC4']",0.9999878479647376,0,0,11
325,Netrin-UNC5B signaling pathway WP4747,0.793358644630233,0.7283739302172482,0.16860392197822993,"['YAP1', 'JUN', 'ITGB4', 'NTN1']",0.9999878479647376,0,0,4
326,IL17 signaling pathway WP2112,0.7944217490390141,0.7056890299184043,0.16240782990935013,"['CEBPB', 'TRAF3IP2', 'IL17RE']",0.9999878479647376,0,0,3
327,Pre-implantation embryo WP3527,0.7944217490390141,0.7056890299184043,0.16240782990935013,"['ZFP36', 'DDIT3', 'HMGA1']",0.9999878479647376,0,0,3
328,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.7955786307846515,0.7426688317890916,0.16983766116656202,"['ADCY10', 'TGFB1', 'CFL1', 'BANF1', 'HRAS']",0.9999878479647376,0,0,5
329,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7994051849302254,0.7524890301104554,0.16847277237126732,"['YAP1', 'PCNA', 'KAT5', 'CDK5', 'H2AFX', 'BAX']",0.9999878479647376,0,0,6
330,Notch Signaling Pathway Netpath WP61,0.7994051849302254,0.7524890301104554,0.16847277237126732,"['PSENEN', 'CDKN1A', 'CCND1', 'HEY1', 'SKP1', 'DLL3']",0.9999878479647376,0,0,6
331,DNA damage response (only ATM dependent) WP710,0.8022543609040095,0.7955950631109867,0.17529311271166356,"['FRAT1', 'JUN', 'CDKN1A', 'TGFB1', 'CDKN1B', 'CCND1', 'TCF7', 'BAX', 'HRAS', 'LDLR', 'PCK2']",0.9999878479647376,0,0,11
332,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.8030023187963227,0.6642501132759402,0.14573493204742122,"['LDHA', 'ACACB']",0.9999878479647376,0,0,2
333,Immune response to tuberculosis WP4197,0.8030023187963227,0.6642501132759402,0.14573493204742122,"['IRF1', 'IFIT3']",0.9999878479647376,0,0,2
334,Kallmann's Syndrome WP5074,0.8030023187963227,0.6642501132759402,0.14573493204742122,"['PLXND1', 'ASCL1']",0.9999878479647376,0,0,2
335,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.8030023187963227,0.6642501132759402,0.14573493204742122,"['HTR2B', 'HRAS']",0.9999878479647376,0,0,2
336,Triacylglyceride synthesis WP325,0.8030023187963227,0.6642501132759402,0.14573493204742122,"['MOGAT1', 'AGPAT1']",0.9999878479647376,0,0,2
337,AMP-activated protein kinase (AMPK) signaling WP1403,0.804053234538296,0.7596415845734646,0.1656700811622704,"['GYS2', 'CCNA2', 'CDKN1A', 'LEPR', 'HMGCR', 'EEF2', 'ACACB']",0.9999878479647376,0,0,7
338,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.8041672286256403,0.6274657809983897,0.13675493439255326,['TCF7'],0.9999878479647376,0,0,1
339,Cancer immunotherapy by CTLA4 blockade WP4582,0.8041672286256403,0.6274657809983897,0.13675493439255326,['PTPN6'],0.9999878479647376,0,0,1
340,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.8041672286256403,0.6274657809983897,0.13675493439255326,['MAFF'],0.9999878479647376,0,0,1
341,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.8041672286256403,0.6274657809983897,0.13675493439255326,['JUN'],0.9999878479647376,0,0,1
342,Osteopontin Signaling WP1434,0.8041672286256403,0.6274657809983897,0.13675493439255326,['SPP1'],0.9999878479647376,0,0,1
343,TCA cycle in senescence WP5050,0.8041672286256403,0.6274657809983897,0.13675493439255326,['GOT1'],0.9999878479647376,0,0,1
344,Integrated breast cancer pathway WP1984,0.8110131965336282,0.8193625616070872,0.1716326566906026,"['PLK3', 'JUN', 'GSK3A', 'GADD45A', 'TRADD', 'ODC1', 'PHB', 'HMGCR', 'JAKMIP1', 'BACH1', 'RASGRP3', 'FOSL2', 'CASP8', 'CCND1', 'BAX', 'FADD', 'FAU']",0.9999878479647376,0,0,17
345,NO/cGMP/PKG mediated Neuroprotection WP4008,0.8115525266855679,0.7055555555555556,0.14732435061695842,"['CNGB3', 'CYCS', 'CALM1', 'CALM2']",0.9999878479647376,0,0,4
346,Nucleotide Excision Repair WP4753,0.8120656543060594,0.7235678719344781,0.1506280811458856,"['PCNA', 'POLD1', 'RPA3', 'POLE2', 'POLE3']",0.9999878479647376,0,0,5
347,Corticotropin-releasing hormone signaling pathway WP2355,0.8143610637607329,0.7693388429752066,0.15798484237090824,"['CRHBP', 'NR4A1', 'HSP90AA1', 'TGFB1', 'JUND', 'PRKCD', 'IL18', 'CRH', 'FOSL2']",0.9999878479647376,0,0,9
348,GABA receptor Signaling WP4159,0.8147236663274693,0.6774070716228467,0.13880496509428836,"['SLC32A1', 'GAD1', 'AP2M1']",0.9999878479647376,0,0,3
349,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.8147236663274693,0.6774070716228467,0.13880496509428836,"['CDKN1B', 'FOXO4', 'HRAS']",0.9999878479647376,0,0,3
350,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.8147236663274693,0.6774070716228467,0.13880496509428836,"['CASP8', 'TGFB1', 'BAX']",0.9999878479647376,0,0,3
351,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.8147236663274693,0.6774070716228467,0.13880496509428836,"['CALM3', 'CALM1', 'CALM2']",0.9999878479647376,0,0,3
352,Zinc homeostasis WP3529,0.8147236663274693,0.6774070716228467,0.13880496509428836,"['SLC39A11', 'SLC39A7', 'SLC39A3']",0.9999878479647376,0,0,3
353,Pancreatic adenocarcinoma pathway WP4263,0.8196599694905822,0.772767198041451,0.15367688674377555,"['CDKN1A', 'TGFB1', 'CCND1', 'GADD45B', 'EGF', 'GADD45A', 'PRKCD', 'PEBP1', 'BAX', 'PLD1']",0.9999878479647376,0,0,10
354,MAPK Signaling Pathway WP382,0.8244008674281045,0.8406778716874883,0.16233353325263816,"['HSPB1', 'FGF1', 'RASGRP3', 'RPS6KA5', 'DUSP10', 'NTF3', 'MKNK2', 'FLNC', 'HRAS', 'DUSP4', 'HSPA8', 'JUN', 'DUSP2', 'JUND', 'TGFB1', 'HSPA1L', 'IL1R1', 'GADD45A', 'DUSP1', 'EGF', 'PRKCD', 'FGF17', 'NR4A1', 'DDIT3', 'FGFR4', 'HSPA1B', 'HSPA1A']",0.9999878479647376,0,0,27
355,Canonical and non-canonical Notch signaling WP3845,0.8258682104006217,0.6272969843427478,0.12001450280717776,"['HEY1', 'DLL3']",0.9999878479647376,0,0,2
356,miRNA regulation of p53 pathway in prostate cancer WP3982,0.8258682104006217,0.6272969843427478,0.12001450280717776,"['CASP8', 'BAX']",0.9999878479647376,0,0,2
357,Monoamine Transport WP727,0.8258682104006217,0.6272969843427478,0.12001450280717776,"['ADORA2A', 'IL1R1']",0.9999878479647376,0,0,2
358,TGF-beta Signaling Pathway WP366,0.8308611686815149,0.7894851936218679,0.14628573533112033,"['YAP1', 'JUN', 'CDKN1A', 'TGFB1', 'JUND', 'CITED1', 'ITGB4', 'FN1', 'NEDD9', 'ETS1', 'PJA1', 'PARD6A', 'CCND1', 'SKP1']",0.9999878479647376,0,0,14
359,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.8336413283640377,0.5646739130434782,0.10274356535365627,['BMP2'],0.9999878479647376,0,0,1
360,Homologous recombination WP186,0.8336413283640377,0.5646739130434782,0.10274356535365627,['POLD1'],0.9999878479647376,0,0,1
361,Leptin Insulin Overlap WP3935,0.8336413283640377,0.5646739130434782,0.10274356535365627,['LEPR'],0.9999878479647376,0,0,1
362,"NAD metabolism, sirtuins and aging WP3630",0.8336413283640377,0.5646739130434782,0.10274356535365627,['ROS1'],0.9999878479647376,0,0,1
363,Neuroinflammation WP4919,0.8336413283640377,0.5646739130434782,0.10274356535365627,['JUN'],0.9999878479647376,0,0,1
364,Circadian rhythm related genes WP3594,0.8402480200150302,0.8052837573385518,0.14016621616942626,"['JUN', 'MAGEL2', 'JUND', 'AHCY', 'SFTPC', 'NR1D1', 'CARTPT', 'HCRTR2', 'PER2', 'PPP1CC', 'DBP', 'ADORA2A', 'ID2', 'UBC', 'CRH', 'ID3', 'RPS27A', 'UBA52', 'SKP1']",0.9999878479647376,0,0,19
365,Fatty Acid Biosynthesis WP357,0.8463157543251427,0.5942336584551546,0.0991554665204446,"['ACSL5', 'ACACB']",0.9999878479647376,0,0,2
366,Glycerolipids and Glycerophospholipids WP4722,0.8463157543251427,0.5942336584551546,0.0991554665204446,"['PLD1', 'CDIPT']",0.9999878479647376,0,0,2
367,NRF2-ARE regulation WP4357,0.8463157543251427,0.5942336584551546,0.0991554665204446,"['AIMP2', 'CEBPB']",0.9999878479647376,0,0,2
368,PKC-gamma calcium signaling pathway in ataxia WP4760,0.8463157543251427,0.5942336584551546,0.0991554665204446,"['TRPC3', 'HOMER3']",0.9999878479647376,0,0,2
369,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.8502439414594489,0.6271280346529666,0.10174022322630304,"['PRKCH', 'PRKCD', 'HRAS']",0.9999878479647376,0,0,3
370,3q29 copy number variation syndrome WP4906,0.8544019724852132,0.6908390228538079,0.10870593967382873,"['CASP7', 'JUN', 'TGFB1', 'DYNLT3', 'SLC51A', 'DYNLL2']",0.9999878479647376,0,0,6
371,Neural Crest Differentiation WP2064,0.855064337379693,0.7051544050862852,0.11041206448451989,"['DLX5', 'ZIC1', 'ASCL1', 'ETS1', 'GFAP', 'RHOB', 'DLL3']",0.9999878479647376,0,0,7
372,Cell Differentiation - Index expanded WP2023,0.8586810475467346,0.5132987483530962,0.07820503346957641,['ID2'],0.9999878479647376,0,0,1
373,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.8586810475467346,0.5132987483530962,0.07820503346957641,['CCK'],0.9999878479647376,0,0,1
374,FOXA2 pathway WP5066,0.8586810475467346,0.5132987483530962,0.07820503346957641,['ABCC2'],0.9999878479647376,0,0,1
375,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.8586810475467346,0.5132987483530962,0.07820503346957641,['TGFB1'],0.9999878479647376,0,0,1
376,NO metabolism in cystic fibrosis WP4947,0.8586810475467346,0.5132987483530962,0.07820503346957641,['DDAH2'],0.9999878479647376,0,0,1
377,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.8586810475467346,0.5132987483530962,0.07820503346957641,['SFRP4'],0.9999878479647376,0,0,1
378,Estrogen signaling pathway WP712,0.8645547871765783,0.5644766651563208,0.08215427335578217,"['JUN', 'GPER1']",0.9999878479647376,0,0,2
379,SARS-CoV-2 mitochondrial interactions WP5038,0.8645547871765783,0.5644766651563208,0.08215427335578217,"['NDUFB9', 'PHB']",0.9999878479647376,0,0,2
380,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.8645547871765783,0.5644766651563208,0.08215427335578217,"['CCND1', 'DKK1']",0.9999878479647376,0,0,2
381,MET in type 1 papillary renal cell carcinoma WP4205,0.866031022653867,0.6769677712210622,0.0973713534757996,"['CDKN1A', 'JUN', 'RPL11', 'GAB1', 'ETS1', 'HRAS']",0.9999878479647376,0,0,6
382,PPAR signaling pathway WP3942,0.8676067184311054,0.656048199890263,0.09316983736611797,"['FABP6', 'ACSL5', 'ANGPTL4', 'ACSBG2', 'PCK2']",0.9999878479647376,0,0,5
383,Regulation of Microtubule Cytoskeleton WP2038,0.8716047322773085,0.6269589317208365,0.08615622399125622,"['SPRED1', 'PARD6A', 'CFL2', 'TESK2']",0.9999878479647376,0,0,4
384,Prostaglandin Synthesis and Regulation WP98,0.8796749693066617,0.5837840372651389,0.0748427439683636,"['HSD11B1', 'EDN1', 'ANXA2']",0.9999878479647376,0,0,3
385,NOTCH1 regulation of endothelial cell calcification WP3413,0.879953281029262,0.4704861111111111,0.06016880448003399,['DLL3'],0.9999878479647376,0,0,1
386,16p11.2 distal deletion syndrome WP4950,0.8807867591032984,0.5375536712192807,0.0682369160004193,"['PLN', 'CD81']",0.9999878479647376,0,0,2
387,Cannabinoid receptor signaling WP3869,0.8807867591032984,0.5375536712192807,0.0682369160004193,"['ADORA2A', 'PRKAR1A']",0.9999878479647376,0,0,2
388,Cell migration and invasion through p75NTR WP4561,0.8807867591032984,0.5375536712192807,0.0682369160004193,"['JUN', 'EFNA3']",0.9999878479647376,0,0,2
389,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.8807867591032984,0.5375536712192807,0.0682369160004193,"['H3F3B', 'H3F3A']",0.9999878479647376,0,0,2
390,MTHFR deficiency WP4288,0.8807867591032984,0.5375536712192807,0.0682369160004193,"['CHDH', 'CYCS']",0.9999878479647376,0,0,2
391,Ebola Virus Pathway on Host WP4217,0.8889166528865127,0.7127744135211739,0.08393047135989044,"['VPS18', 'HLA-B', 'HLA-A', 'ITGA5', 'FLNC', 'MFGE8', 'ACTB', 'CLEC4G', 'ACTG1', 'HLA-E', 'RHOB']",0.9999878479647376,0,0,11
392,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8897392342091685,0.6267896753377697,0.07322586617649347,"['CASP8', 'CXCL12', 'TRADD', 'ISG15', 'FADD']",0.9999878479647376,0,0,5
393,p53 transcriptional gene network WP4963,0.8897392342091685,0.6267896753377697,0.07322586617649347,"['CDKN1A', 'GADD45A', 'BAX', 'ISG15', 'RPRM']",0.9999878479647376,0,0,5
394,Amyotrophic lateral sclerosis (ALS) WP2447,0.8923662859911388,0.5642792384406164,0.06425932752160392,"['BAX', 'NEFH', 'SOD1']",0.9999878479647376,0,0,3
395,Disruption of postsynaptic signaling by CNV WP4875,0.8923662859911388,0.5642792384406164,0.06425932752160392,"['ARC', 'YWHAG', 'SHANK1']",0.9999878479647376,0,0,3
396,Type 2 papillary renal cell carcinoma WP4241,0.8923662859911388,0.5642792384406164,0.06425932752160392,"['CDKN1A', 'TGFB1', 'ELOB']",0.9999878479647376,0,0,3
397,Head and Neck Squamous Cell Carcinoma WP4674,0.8947268404539791,0.657932182864063,0.07318627951355727,"['CDKN1A', 'CASP8', 'CCND1', 'DDIT4', 'GAB1', 'FADD', 'HRAS']",0.9999878479647376,0,0,7
398,ATM Signaling Network in Development and Disease  WP3878,0.8948879454942046,0.5938656164220074,0.06595279664573937,"['KAT5', 'CDK5', 'H2AFX', 'HSPB1']",0.9999878479647376,0,0,4
399,"GPCRs, Other WP117",0.8948879454942046,0.5938656164220074,0.06595279664573937,"['ADGRV1', 'ADORA2A', 'GNRHR', 'MCHR2']",0.9999878479647376,0,0,4
400,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.8952025098839738,0.5130782221856077,0.05680048788715434,"['CDKN1A', 'BMP2']",0.9999878479647376,0,0,2
401,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.8980246667708647,0.43426003344481606,0.04670802885215239,['RPH3AL'],0.9999878479647376,0,0,1
402,Mammalian disorder of sexual development WP4842,0.8980246667708647,0.43426003344481606,0.04670802885215239,['FST'],0.9999878479647376,0,0,1
403,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.8980246667708647,0.43426003344481606,0.04670802885215239,['LDHA'],0.9999878479647376,0,0,1
404,Riboflavin and CoQ disorders WP5037,0.8980246667708647,0.43426003344481606,0.04670802885215239,['RFK'],0.9999878479647376,0,0,1
405,Transcription co-factors SKI and SKIL protein partners WP4533,0.8980246667708647,0.43426003344481606,0.04670802885215239,['SATB2'],0.9999878479647376,0,0,1
406,Gastrin signaling pathway WP4659,0.9032085665160065,0.6966445491815849,0.07091965622330304,"['JUN', 'BMP2', 'CDKN1A', 'PRKCH', 'CDKN1B', 'CCND1', 'KAT5', 'ANXA2', 'PRKCD', 'HRAS', 'RHOB']",0.9999878479647376,0,0,11
407,IL-5 signaling pathway WP127,0.9038425928175831,0.5460328137338052,0.055203948450677595,"['GSK3A', 'SPRED1', 'JUN']",0.9999878479647376,0,0,3
408,Signaling of Hepatocyte Growth Factor Receptor WP313,0.9038425928175831,0.5460328137338052,0.055203948450677595,"['JUN', 'GAB1', 'HRAS']",0.9999878479647376,0,0,3
409,Vitamin D-sensitive calcium signaling in depression WP4698,0.9038425928175831,0.5460328137338052,0.055203948450677595,"['CALB1', 'GPX4', 'PVALB']",0.9999878479647376,0,0,3
410,Hepatitis B infection WP4666,0.9056961233364945,0.7112446283622473,0.0704498002970446,"['JUN', 'CDKN1A', 'TICAM2', 'TGFB1', 'PCNA', 'ATP6AP1', 'SLC10A1', 'YWHAB', 'CASP8', 'CYCS', 'BAX', 'FADD', 'HRAS']",0.9999878479647376,0,0,13
411,Sphingolipid pathway WP1422,0.9079809026060176,0.4907310730679065,0.04737121905377514,"['CERS4', 'SERINC1']",0.9999878479647376,0,0,2
412,Amino Acid metabolism WP3925,0.9108451271496767,0.636606017989511,0.05944779737067449,"['LDHA', 'PKM', 'OAT', 'GOT1', 'MDH2', 'ODC1', 'PYCR1']",0.9999878479647376,0,0,7
413,Canonical and non-canonical TGF-B signaling WP3874,0.9133766519653376,0.40320910973084884,0.03653354370707815,['TGFB1'],0.9999878479647376,0,0,1
414,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.9133766519653376,0.40320910973084884,0.03653354370707815,['ALOX12'],0.9999878479647376,0,0,1
415,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.9133766519653376,0.40320910973084884,0.03653354370707815,['FRAT1'],0.9999878479647376,0,0,1
416,MAPK pathway in congenital thyroid cancer WP4928,0.9133766519653376,0.40320910973084884,0.03653354370707815,['JUN'],0.9999878479647376,0,0,1
417,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.9133766519653376,0.40320910973084884,0.03653354370707815,['JUN'],0.9999878479647376,0,0,1
418,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.9133766519653376,0.40320910973084884,0.03653354370707815,['CCND1'],0.9999878479647376,0,0,1
419,PPAR-alpha pathway WP2878,0.9133766519653376,0.40320910973084884,0.03653354370707815,['CCND1'],0.9999878479647376,0,0,1
420,Leptin signaling pathway WP2034,0.9180765938058397,0.6264507013825815,0.053545533114371865,"['GSK3A', 'CCND1', 'CFL2', 'LEPR', 'BAX', 'HRAS', 'ACACB']",0.9999878479647376,0,0,7
421,Nanoparticle-mediated activation of receptor signaling WP2643,0.9192881081868136,0.47024618637668025,0.03957389883135082,"['FN1', 'HRAS']",0.9999878479647376,0,0,2
422,Trans-sulfuration and one-carbon metabolism WP2525,0.9192881081868136,0.47024618637668025,0.03957389883135082,"['AHCY', 'MAT2B']",0.9999878479647376,0,0,2
423,ErbB signaling pathway WP673,0.9221085810257483,0.6503496503496503,0.05273834603768192,"['SHC4', 'CDKN1A', 'JUN', 'CDKN1B', 'SHC3', 'CCND1', 'EGF', 'GAB1', 'HRAS']",0.9999878479647376,0,0,9
424,Osteoblast differentiation WP4787,0.9221085810257483,0.6503496503496503,0.05273834603768192,"['BMP2', 'PRKCH', 'HEY1', 'PRKCD', 'FGF1', 'FGFR4', 'GLI3', 'GLI2', 'DLL3']",0.9999878479647376,0,0,9
425,Regulation of toll-like receptor signaling pathway WP1449,0.9221085810257483,0.6503496503496503,0.05273834603768192,"['JUN', 'TICAM2', 'CASP8', 'PELI3', 'SFTPD', 'TIFA', 'SPP1', 'PTPN6', 'FADD']",0.9999878479647376,0,0,9
426,RANKL/RANK signaling pathway WP2018,0.922852513093981,0.5502792987113545,0.04417964015843706,"['JUN', 'SPI1', 'CALCR', 'PAPSS2']",0.9999878479647376,0,0,4
427,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.922852513093981,0.5502792987113545,0.04417964015843706,"['EIF4A2', 'RPS6KA5', 'PRKCD', 'PIM1']",0.9999878479647376,0,0,4
428,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9246088505420726,0.7040793072014585,0.05518890106227887,"['SHC4', 'LINGO1', 'JUN', 'RAB3A', 'SHC3', 'PRKCD', 'EEF2', 'ACACB', 'BMP2', 'RPS6KA5', 'CDK5', 'CFL1', 'NTF3', 'SPP1', 'HRAS']",0.9999878479647376,0,0,15
429,BMP Signaling Pathway in Eyelid Development WP3927,0.9264182963623016,0.37629830917874396,0.028760262420299745,['JUN'],0.9999878479647376,0,0,1
430,Globo Sphingolipid Metabolism WP1424,0.9264182963623016,0.37629830917874396,0.028760262420299745,['FUT2'],0.9999878479647376,0,0,1
431,Glycosaminoglycan degradation WP4815,0.9264182963623016,0.37629830917874396,0.028760262420299745,['HYAL1'],0.9999878479647376,0,0,1
432,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.9264182963623016,0.37629830917874396,0.028760262420299745,['NFKBIE'],0.9999878479647376,0,0,1
433,22q11.2 copy number variation syndrome WP4657,0.9279785460027945,0.6420655926352129,0.04799226175729265,"['CLDN5', 'CYP26A1', 'RANBP1', 'MRPL40', 'OAT', 'SERPIND1', 'THAP7', 'ALDH1A2', 'RAN']",0.9999878479647376,0,0,9
434,Intraflagellar transport proteins binding to dynein WP4532,0.9292773756630296,0.45140009062075215,0.033109298488994104,"['DYNLT3', 'DYNLL2']",0.9999878479647376,0,0,2
435,Neovascularisation processes WP4331,0.9292773756630296,0.45140009062075215,0.033109298488994104,"['TGFB1', 'CXCL12']",0.9999878479647376,0,0,2
436,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.9292773756630296,0.45140009062075215,0.033109298488994104,"['YAP1', 'FOXO4']",0.9999878479647376,0,0,2
437,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.931924822016464,0.49773345421577514,0.03509176673773803,"['ITGB4', 'ACTB', 'ACTG1']",0.9999878479647376,0,0,3
438,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.9374971512814573,0.35275135869565216,0.022767122903073752,['MKNK2'],0.9999878479647376,0,0,1
439,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.9374971512814573,0.35275135869565216,0.022767122903073752,['HRAS'],0.9999878479647376,0,0,1
440,Neural Crest Cell Migration during Development WP4564,0.9380891588704627,0.43400369453835697,0.02773729867727851,"['JUN', 'EPHB3']",0.9999878479647376,0,0,2
441,Interleukin-11 Signaling Pathway WP2332,0.9394611994559002,0.483473643310452,0.030192329577203064,"['TGFB1', 'BGLAP', 'HRAS']",0.9999878479647376,0,0,3
442,G Protein Signaling Pathways WP35,0.9400218477961287,0.6092562348809509,0.03768381512727187,"['GNG3', 'PRKCH', 'PRKD3', 'PRKAR1A', 'PRKCD', 'CALM1', 'HRAS', 'CALM2']",0.9999878479647376,0,0,8
443,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9421454001390088,0.5888608727479767,0.03509355455470478,"['MC4R', 'TG', 'PAX8', 'NPY', 'DIO1', 'HRAS', 'TSHR']",0.9999878479647376,0,0,7
444,Autophagy WP4923,0.9458514965066369,0.41789592038799106,0.023264141643336653,"['MAP1LC3B', 'ATG101']",0.9999878479647376,0,0,2
445,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9458514965066369,0.41789592038799106,0.023264141643336653,"['HEXIM1', 'SUPT4H1']",0.9999878479647376,0,0,2
446,Nuclear receptors WP170,0.9458514965066369,0.41789592038799106,0.023264141643336653,"['NR4A1', 'ESRRB']",0.9999878479647376,0,0,2
447,PDGFR-beta pathway WP3972,0.9458514965066369,0.41789592038799106,0.023264141643336653,"['JUN', 'HRAS']",0.9999878479647376,0,0,2
448,Ras signaling WP4223,0.9461325344614806,0.6823916317760367,0.03778581244228288,"['SHC4', 'SHC3', 'RASA4B', 'GAB1', 'FOXO4', 'PLD1', 'ETS1', 'RASGRP3', 'GNG3', 'RASA4', 'CALM3', 'CALM1', 'FGFR4', 'CALM2', 'HRAS', 'ARF6']",0.9999878479647376,0,0,16
449,miRNAs involvement in the immune response in sepsis WP4329,0.9469085053379926,0.3319746376811594,0.01811014791836925,['IRF1'],0.9999878479647376,0,0,1
450,Purine metabolism and related disorders WP4224,0.9469085053379926,0.3319746376811594,0.01811014791836925,['PRPS1'],0.9999878479647376,0,0,1
451,Vitamin D in inflammatory diseases WP4482,0.9469085053379926,0.3319746376811594,0.01811014791836925,['DUSP1'],0.9999878479647376,0,0,1
452,Endoderm differentiation WP2853,0.9536243697250807,0.6257709028409665,0.029714998836770687,"['DUSP4', 'DUSP5', 'DUSP2', 'TGFB1', 'TRIM5', 'TCEAL2', 'TCF7', 'SLC2A12', 'DKK1', 'GLI2', 'NME1']",0.9999878479647376,0,0,11
453,Prolactin Signaling Pathway WP2037,0.9546570313189278,0.5454146105750224,0.025308946448945623,"['JUN', 'IRF1', 'PTPN6', 'HRAS', 'PRLR', 'YWHAG']",0.9999878479647376,0,0,6
454,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.9549032399051292,0.31350644122383253,0.014466837215586644,['MAP1LC3A'],0.9999878479647376,0,0,1
455,NAD+ biosynthetic pathways WP3645,0.9549032399051292,0.31350644122383253,0.014466837215586644,['ACMSD'],0.9999878479647376,0,0,1
456,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.9549032399051292,0.31350644122383253,0.014466837215586644,['RPS6KA5'],0.9999878479647376,0,0,1
457,Cardiac Hypertrophic Response WP2795,0.9549180659533216,0.49026915113871633,0.02261598699892233,"['TGFB1', 'EGF', 'CALM1', 'CALM2']",0.9999878479647376,0,0,4
458,EGF/EGFR signaling pathway WP437,0.9558949997327608,0.6670652412558478,0.030089448504543002,"['NDUFA13', 'JUN', 'JUND', 'PCNA', 'EGF', 'PRKCD', 'GAB1', 'PEBP1', 'FOXO4', 'PLD1', 'RPS6KA5', 'CFL1', 'SPRY2', 'HRAS', 'AP2M1', 'ARF6']",0.9999878479647376,0,0,16
459,Histone Modifications WP2369,0.9576770298274889,0.44519730877511093,0.01925241847985976,"['SET', 'H3F3B', 'H3F3A']",0.9999878479647376,0,0,3
460,MAPK Cascade WP422,0.9586813636225674,0.3890130150149212,0.01641499480904943,"['JUN', 'HRAS']",0.9999878479647376,0,0,2
461,Neural Crest Cell Migration in Cancer WP4565,0.9586813636225674,0.3890130150149212,0.01641499480904943,"['JUN', 'EPHB3']",0.9999878479647376,0,0,2
462,Fatty acid beta-oxidation WP143,0.9639484187064579,0.37601570759703973,0.013806354250367008,"['TPI1', 'ACSL5']",0.9999878479647376,0,0,2
463,IL-2 signaling pathway WP49,0.9639484187064579,0.37601570759703973,0.013806354250367008,"['JUN', 'HRAS']",0.9999878479647376,0,0,2
464,Toll-like Receptor Signaling Pathway WP75,0.9664061539744485,0.4943563536791161,0.016892692430516096,"['JUN', 'TICAM2', 'CASP8', 'SPP1', 'FADD']",0.9999878479647376,0,0,5
465,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.9665573121129964,0.5402000671867419,0.0183747342986337,"['SHC4', 'SHC3', 'CCND1', 'EGF', 'GAB1', 'BAX', 'HRAS']",0.9999878479647376,0,0,7
466,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.9668144058556265,0.42286944696282863,0.014271306668081657,"['MAP1LC3A', 'ATG101', 'CP']",0.9999878479647376,0,0,3
467,Hippo-Merlin Signaling Dysregulation WP4541,0.9674037979263902,0.5562903506262585,0.01843506874995332,"['PPP1CC', 'CCND1', 'PRKAR1A', 'ITGB4', 'ITGA5', 'FGFR4', 'HRAS', 'CDH18']",0.9999878479647376,0,0,8
468,Angiogenesis WP1539,0.9674633916833004,0.2821105072463768,0.009331564707751924,['TIMP2'],0.9999878479647376,0,0,1
469,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.9674633916833004,0.2821105072463768,0.009331564707751924,['ANGPT2'],0.9999878479647376,0,0,1
470,Toll-like Receptor Signaling related to MyD88 WP3858,0.9674633916833004,0.2821105072463768,0.009331564707751924,['TICAM2'],0.9999878479647376,0,0,1
471,DNA Repair Pathways Full Network WP4946,0.9711916116537315,0.5897265912734521,0.01723859038114544,"['BRIP1', 'FEN1', 'NEIL2', 'PCNA', 'CENPX', 'POLD1', 'RPA3', 'POLE2', 'APEX1', 'H2AFX', 'POLE3']",0.9999878479647376,0,0,11
472,Pathways Regulating Hippo Signaling WP4540,0.9723206903438045,0.5257099606418407,0.014756468626046338,"['PRKCH', 'PRKD3', 'PRKAR1A', 'PRKCD', 'TCF7', 'FGFR4', 'CDH18']",0.9999878479647376,0,0,7
473,1q21.1 copy number variation syndrome WP4905,0.9723637520103278,0.26865510697032435,0.007529143748050456,['FMO5'],0.9999878479647376,0,0,1
474,EPO Receptor Signaling WP581,0.9723637520103278,0.26865510697032435,0.007529143748050456,['EPOR'],0.9999878479647376,0,0,1
475,Nanoparticle triggered autophagic cell death WP2509,0.9723637520103278,0.26865510697032435,0.007529143748050456,['MAP1LC3A'],0.9999878479647376,0,0,1
476,Sphingolipid Metabolism (general overview) WP4725,0.9723637520103278,0.26865510697032435,0.007529143748050456,['CERS4'],0.9999878479647376,0,0,1
477,Regulation of Actin Cytoskeleton WP51,0.9726141567152972,0.5976774443025686,0.016596203027313402,"['FGF17', 'EGF', 'CFL2', 'TMSB4X', 'CHRM5', 'CFL1', 'FN1', 'WAS', 'FGF1', 'FGFR4', 'ACTB', 'ACTG1']",0.9999878479647376,0,0,12
478,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.974065642027864,0.4026680481802875,0.010580740522890701,"['RPS6KA5', 'IL1R1', 'MKNK2']",0.9999878479647376,0,0,3
479,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.9765262945628964,0.2564229249011858,0.00609096801771847,['TICAM2'],0.9999878479647376,0,0,1
480,Fluoropyrimidine Activity WP1601,0.9765262945628964,0.2564229249011858,0.00609096801771847,['TYMP'],0.9999878479647376,0,0,1
481,Sphingolipid Metabolism (integrated pathway) WP4726,0.9765262945628964,0.2564229249011858,0.00609096801771847,['CERS4'],0.9999878479647376,0,0,1
482,MECP2 and Associated Rett Syndrome WP3584,0.980298324723678,0.4543059539839588,0.009039934635514897,"['GABRR2', 'DLX5', 'SST', 'GAD1', 'FKBP5']",0.9999878479647376,0,0,5
483,Wnt Signaling Pathway WP363,0.982185135808282,0.375732849803566,0.006753970459425586,"['GSK3A', 'FRAT1', 'CCND1']",0.9999878479647376,0,0,3
484,Gastric Cancer Network 2 WP2363,0.983065401229895,0.23501660628019325,0.004013996389936402,['CACYBP'],0.9999878479647376,0,0,1
485,Insulin Signaling WP481,0.983317558530589,0.5875497229116378,0.009884443359216464,"['XBP1', 'JUN', 'GSK3A', 'PRKCH', 'SHC3', 'RRAD', 'PRKCD', 'GAB1', 'GYS2', 'RPS6KA5', 'HRAS', 'SGK2', 'VAMP2', 'ARF6']",0.9999878479647376,0,0,14
486,Pathways affected in adenoid cystic carcinoma WP3651,0.9838042533327758,0.4097464440321583,0.006690475670293347,"['MYCBP', 'FGFR4', 'HRAS', 'FOXP2']",0.9999878479647376,0,0,4
487,PDGF Pathway WP2526,0.9843117107207461,0.3131953884106127,0.004952449968717793,"['JUN', 'HRAS']",0.9999878479647376,0,0,2
488,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9856008980064984,0.40239714933592485,0.0058362777454226385,"['GHR', 'DUSP2', 'IL3RA', 'CSF2RA']",0.9999878479647376,0,0,4
489,Glycerophospholipid Biosynthetic Pathway WP2533,0.9856164491217503,0.22559782608695653,0.003268460603262253,['CDIPT'],0.9999878479647376,0,0,1
490,Lipid Metabolism Pathway WP3965,0.9856164491217503,0.22559782608695653,0.003268460603262253,['PRKAR1A'],0.9999878479647376,0,0,1
491,IL-1 signaling pathway WP195,0.9878384159213597,0.3521645512239347,0.0043091351912367465,"['JUN', 'IL1R1', 'HSPB2']",0.9999878479647376,0,0,3
492,Splicing factor NOVA regulated synaptic proteins WP4148,0.9881656320363263,0.29666372546681613,0.003531767270448641,"['EPB41', 'NCDN']",0.9999878479647376,0,0,2
493,ESC Pluripotency Pathways WP3931,0.9885959906073885,0.4690432939751741,0.0053797078877665504,"['FGF17', 'JUN', 'EGF', 'GAB1', 'FGF1', 'FGFR4', 'HRAS']",0.9999878479647376,0,0,7
494,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9886574516439625,0.4202332258850936,0.004793754067052036,"['EDN1', 'TGFB1', 'EGF', 'CALM1', 'CALM2']",0.9999878479647376,0,0,5
495,Chemokine signaling pathway WP3929,0.9893829562463071,0.5013186318631864,0.005350978166572449,"['SHC4', 'HCK', 'GNG3', 'SHC3', 'CXCL12', 'PRKCD', 'WAS', 'CXCL14', 'HRAS']",0.9999878479647376,0,0,9
496,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.9896237763905726,0.20885332796564682,0.002178430420442688,['JUN'],0.9999878479647376,0,0,1
497,DNA IR-damage and cellular response via ATR WP4016,0.9898638206269638,0.41401996370235933,0.004217994086452791,"['SEM1', 'FEN1', 'BRIP1', 'PCNA', 'H2AFX']",0.9999878479647376,0,0,5
498,Male infertility WP4673,0.9907032261524602,0.45806138183047124,0.004278411747744485,"['NANOS1', 'ABCB1', 'MSH5', 'HMGA1', 'PEX10', 'TEX15', 'ETV5']",0.9999878479647376,0,0,7
499,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9927529607636497,0.4820649350649351,0.003506263916458749,"['CLDN5', 'CLDN20', 'TGFB1', 'ID2', 'EIF5A2', 'FN1', 'ITGA5', 'HRAS', 'DLL3']",0.9999878479647376,0,0,9
500,IL-4 signaling pathway WP395,0.9933039870021395,0.2683237318488791,0.0018027415448820213,"['CEBPB', 'PTPN6']",0.9999878479647376,0,0,2
501,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9954139054826021,0.17614923007246377,0.000809695109838197,['HCK'],0.9999878479647376,0,0,1
502,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.995650627907262,0.2503750692241857,0.0010913494053009728,"['ARC', 'HRAS']",0.9999878479647376,0,0,2
503,Joubert Syndrome WP4656,0.9962092955274463,0.33603411513859277,0.0012762264529732796,"['TMEM17', 'KAT5', 'UNC119', 'PDE6B']",0.9999878479647376,0,0,4
504,Interferon type I signaling pathways WP585,0.9967438022883166,0.23968224893713427,0.0007817262099037737,"['RPS6KA5', 'PTPN6']",0.9999878479647376,0,0,2
505,Ectoderm Differentiation WP2858,0.9971828216910715,0.42423255295620343,0.0011968253740379296,"['MAFB', 'ARHGDIG', 'PIM1', 'HESX1', 'SPRY2', 'JAKMIP1', 'PTPN13', 'GLI3']",0.9999878479647376,0,0,8
506,Kit receptor signaling pathway WP304,0.9971839732564348,0.2346699894275789,0.0006617691839365898,"['PTPN6', 'HRAS']",0.9999878479647376,0,0,2
507,Notch Signaling WP268,0.9971900471170694,0.16101190476190477,0.00045307272100637033,['DLL3'],0.9999878479647376,0,0,1
508,Mesodermal commitment pathway WP2857,0.9979106779820641,0.39348773841961854,0.000822982633227266,"['YAP1', 'CCND1', 'PRKAR1A', 'TRIM5', 'SLC2A12', 'RPL38', 'DKK1']",0.9999878479647376,0,0,7
509,Ciliopathies WP4803,0.998508342386887,0.4613514069621713,0.0006886921127247897,"['PKHD1', 'TMEM17', 'EVC', 'ARL2BP', 'MAK', 'DCDC2', 'UNC119', 'CCDC65', 'AK7', 'DNAI1', 'GLI3', 'GLI2']",0.9999878479647376,0,0,12
510,Thermogenesis WP4321,0.9991566374199115,0.31579457166744834,0.00026644169401578697,"['ADCY10', 'ACSL5', 'HRAS', 'ACTB', 'ACTG1']",0.9999878479647376,0,0,5
511,Integrin-mediated Cell Adhesion WP185,0.9991746059946567,0.2847154051494015,0.00023509942682078494,"['SHC3', 'ITGB4', 'ITGA5', 'HRAS']",0.9999878479647376,0,0,4
512,mRNA Processing WP411,0.9992247315809698,0.38072062775779886,0.00029527515271949743,"['SF3B5', 'LSM7', 'SF3A1', 'CSTF2T', 'SNRPE', 'SNU13', 'HNRNPH2', 'SRSF9']",0.9999878479647376,0,0,8
513,Fragile X Syndrome  WP4549,0.999237758768054,0.3607354448416369,0.00027507227892249227,"['EEF1A1', 'ARC', 'PRKAR1A', 'GAD1', 'GAB1', 'AP2M1', 'SHANK1']",0.9999878479647376,0,0,7
514,Ciliary landscape WP4352,0.999257011519225,0.4821597556251808,0.0003583722940581754,"['YAP1', 'SSNA1', 'DYNLT3', 'H3F3A', 'COPS7A', 'COX6C', 'DYNLL2', 'LSM4', 'PSMD8', 'EXOSC4', 'CDH23', 'TMED1', 'VIM', 'CALM1', 'COPS8', 'CALM2']",0.9999878479647376,0,0,16
515,Energy Metabolism WP1541,0.9993526255770636,0.12798501317523056,8.288105448174368e-05,['UCP3'],0.9999878479647376,0,0,1
516,Rett syndrome causing genes WP4312,0.9996025370967037,0.11978684859697811,4.762029289704249e-05,['SATB2'],0.9999878479647376,0,0,1
517,Genes related to primary cilium development (based on CRISPR) WP4536,0.9999843303651884,0.17179491923696041,2.6919847381934095e-06,"['TMEM17', 'EVC', 'TULP3']",0.9999878479647376,0,0,3
518,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9999878479647376,0.19850300002006702,2.4122301127167584e-06,"['GSK3A', 'RPS6KA5', 'SHC3', 'HRAS']",0.9999878479647376,0,0,4
